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ABSTRACT 
In order to cure critical size bone defects, three dimensional scaffolds are required. The bone has a functionally 
graded structure, with the outer cortical bone having with 10-15% of porosity and inner cancellous bone possess 
50-90% of porosity. Thus functionally graded scaffolds, fabricated with Class A biomaterial can be the better 
therapeutic design for curing critical size bone defects. In this work, an attempt had been made to develop 
porosity gradient bioglass scaffold. 45S5 bioglass and other two glasses, viz. 2P (with 2 wt.% P2O5)  & 4P (with 4 
wt.% P2O5) had been chosen to fabricate the scaffold. The bioactive glasses had been synthesized by melt quench 
method. Differential Scanning Calorimetry and Dilatometric study had been carried out to observe the thermal 
and sintering behavior of these bioactive glasses. Cytotoxicity, Haemocompatibility and Protein Absorption 
studies had been carried out on bioactive glasses as well as on sintered glass product. Porous scaffold preparation 
has been achieved using naphthalene as a pore former (0 wt.%, 30 wt.% & 50 wt.%), shaping by  uniaxial 
pressing followed by sintering. Initially, single layer porous scaffolds had been fabricated and sintered at 800°C, 
850°C & 900°C. Apparent porosity and bulk density had been measured for those single layer scaffolds and XRD 
phase analysis had been carried out. Diametral Tensile strength and flexural strength of those single layer 
scaffolds had been evaluated. Functionally graded scaffolds had been fabricated by incorporating 0wt.% 
naphthalene on outer layer and 30 wt.% & 50wt.% naphthalene on the inner layer, which had been sintered at 
800°C, 850°C & 900°C. Apparent porosity and bulk density had been measured for the entire FGM system and 
graded layers separately. Splitting tensile strength had been calculated for the functionally graded scaffolds. Cell 
viability had been evaluated on those functionally graded scaffolds. The functionally graded scaffolds had been 
soaked in SBF for 1, 4, 7 & 14 days to observe the carbonated hydroxyapatite layer formation. 
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CHAPTER 1 
INTRODUCTION 
1 
1.1 GENERAL INTRODUCTION 
Bone is a complex organ formed by the combined work of bone (osseous) tissue, cartilage, dense 
connective tissues, epithelium, adipose tissue and nervous tissue [1]. Bone tissues are predominately 
called as living dynamic tissue, since they continuously engaged in the bone remodeling process: new 
bone building and deterioration of old bones. In other words, remodeling is a mechanism with a 
combination of both resorption and re-deposition of minerals on itself. Apart from blood cells, the 
regeneration capability of bone tissue had been more vital when compared to the skin tissues, neurons 
and muscle tissues [2]. Excluding the larger bone defects, some of the bone defects will get healed 
spontaneously during the bone remodeling process itself. But at certain times, this bone wound healing 
eventually failed on the critical size defects (CSD). In the recent years, CSD had been technically 
defined as the intraosseous wound which would not heal spontaneously without any surgical 
intervention [3].  
Before analyzing the bone healing mechanism, it is required to observe the anatomical features 
of bone. Bones comprises with outer cortical and inner cancellous /spongy bone layers (refer Fig 1.1). 
The outer cortical bone layer acts as a protective layer to the spongy bone, during proliferation or at any 
stage of remodeling. The cortical bone possesses around 10-15% of porosity, where the pores act as 
attachment points for the tendons and muscular tissues. The cancellous or spongy bone layer is highly 
vascularized porous structure, where the macroscopic spaces had been filled with red bone marrow and 
yellow bone marrow. It contains 50-90% of porosity, where the pores present in the spongy bone 
structure acts as pathways for various mechanisms. The production of blood cells, nutrient transport, 
storage and release of mineral salts had been carried out within the spongy bone. Table 1.1 illustrates the 
mechanical properties of cortical and cancellous bone layer of the human bone.   
Table 1.1- Summary of mechanical properties of the human bone [4] 
Compressive 
Strength 
(MPa) 
Flexural 
Strength 
(MPa) 
Tensile 
Strength 
(MPa) 
Modulus 
(GPa) 
Fracture 
Toughness 
(MpA-m
1/2
) 
Porosity 
(%) 
Cortical 
or compact 
bone 
100 - 150 135 – 193 50 – 151 10 – 20 2 – 12 5 – 10 
Cancellous 
or Spongy 
bone 
2-12 10 - 20 1 - 5 0.1 - 5 0.1 – 0.8 50 – 90 
2 
Fig 1.1 (a) Cortical and cancellous bone layer showing the graded structure [1] 
Fig 1.1(b) macroscopic view of the bone showing cortical and cancellous bone layer [1] 
As the porosity decreases from the outer layer to the core, bones can be called as porosity gradient 
structure. Support, protection, associating in movement, mineral storage, production of red bone marrow 
and triglyceride storage are some of the major functions of bone. Since each layer of the bone performs 
a specific function, the bone is said to be functionally graded material (FGM). Thus, the bone 
alternatives with the similar architecture of the bone may attain enhanced biological recognition. 
1.2 Therapeutics for bone defects    
In general, either larger or small bone defects, the treatment towards the bone defects had been 
initiated during the pre-historic age itself. Almost several centuries ago, when a tissue is damaged or 
diseased, with minor medication, the offending parts were generally removed for the betterment of 
patient’s life. As the diseased part or damaged tissue interrupts various biological mechanisms and 
contaminate the surrounding tissues, a partial improvement had been achieved by the removal of those 
tissues [5]. During the last century, surgeons demanded tissue replacements and bone fillers for the 
spaces created during the removal of tissues. Several investigations had been carried out and finally two 
alternative options had been emerged out: (1) transplant (2) implant.  
CANCELLOUS BONE 
LAYER 
CORTICAL BONE 
LAYER 
Fig 1.1(b) 
Fig 1.1(a) 
CANCELLOUS BONE 
LAYER 
CORTICAL BONE 
LAYER 
3 
The initial days of implantation had flourished with the reunion of damaged bones which had 
been done by using metal plates and screw fixation. Depends on the condition of the patient, the metal 
plates and screws had been fixed externally and sometimes internally too (Fig 1.1). When entire bone 
was damaged or diseased, these fixation devices were unhelpful. During this situation, surgeons 
preferred metallic implants, which is actually the commencement of the first generation of synthetic / 
man-made or biomaterials. Simultaneously, on the other side of the shore, various investigations had 
been progressed for the development of transplants. Harvesting a tissue from a donor and transplanting 
to a host is the simple phenomena for transplantation procedure. If the donor and the patient are the 
same individual, then they are called as Autografts [6]. When the donor and the recipient are different 
individuals, then they are called as allografts. Heterografts or Xenografts are harvested from the other 
species, which had been considered as the last option for tissue replacements.       
Fig – 1.2 Treatment methods with metal plates and screws by fixing (a) externally (b) internally [7,8] 
This grafting technology had many times focused on the critical size bone defects. But a wide 
range of limitations had been associated along with these Autografts and allografts. The former created 
additional pain since the donor and the recipient are from the same individual. The major consequence 
faced by the allografts is the rejection of donor tissues by the recipient tissue, majorly due to disease 
transfer and other contamination evolved while executing the grafting protocols [9].  
Fig – 1.2 (b) 
Fig – 1.2 (a) 
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Due to the scarcity of the donors, graft pieces had been procured from the graft bank. Non-
availability of fresh graft pieces sometimes created cell adhesions and inflammation surrounding the 
recipient site. These problems had been overcome by the implants, with the synthetic / man made 
biomaterials. 
1.3 Metallic implants 
As mentioned earlier, the first generation of biomaterials had been commenced with the metallic 
implants. Except minor inflammation and cell damage during adhesions, no major critical issues had 
been raised from the patient’s side, when the trauma cases had been treated by external fixation. When 
the physicians opted for internal fixation of broken bones, they faced several problems during post-
surgical periods. Either to support for bone healing or replacement of entire tissue, metallic implants had 
created problems by post-surgical inflammation and certain times by leaching out or releasing toxic 
metal ions.  
It is a widely accepted fact that the metallic implants are the best alternative for load bearing 
positions. But it lacks biological recognition at the implant-host interface, which had triggered the 
material scientist and ortho-surgeons to explore another compatible solution. Since bio-incompatibility 
was the serious issue with the metallic implants, they expected a material which completely behaves as 
bio-inert as far as possible [10]. In the year 1975, α- Al2O3 had been identified as the first bio-inert 
material, by which the surgeons thought to utilize as artificial hip prosthesis instead of metallic implants. 
Low wear and elastic modulus of around 380 GPa are the properties observed with α- Al2O3 as a hip 
prosthesis. These alumina based implants had partially performed the functions of metallic implants and 
had drastically created a biocompatible environment by its bio-inert nature. As a result, these α- Al2O3
ceramic implants had discarded various metallic implants as bone alternatives. [11].  
It was a big astonishment that L.L.Hench [12] broke the incompatibility barrier with his 45S5 
bioglass in the year 1970 itself, even before the discovery of α- Al2O3. In order to preserve the 
mechanical properties of metals within the implant and also to afford biocompatible environment, 
bioglass coatings had been provided on the metallic surfaces [13]. Our human body fluid comprises a 
combination of various metal ions. Furthermore, the optimum level of metal ions leached out from the 
metallic implants can take part in the bone remodeling process. The role of different metal ions in bone 
remodeling process had been illustrated in table 1.2.  
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Table 1.2 Metal ions and its role in various mechanisms [14] 
S.No Metal ions Role 
1. Li+ Osteogenesis 
2. Zn2+ Osteogenesis 
3. Mg2+ Angiogenesis 
4. Sr2+ Osteogenesis 
5. Cu+ Angiogenesis 
6. Co2+ Angiogenesis 
7. B3+ Osteogenesis / Angiogenesis 
8. Mn2+ & Mn3+ Osteogenesis 
9. Si4+ Osteogenesis / Angiogenesis 
Angiogenesis is the formation of new blood vessel and osteogenesis is the formation of osteoblast (bone 
cells). These two mechanisms can be considered as constructive stages of the bone remodeling process. 
In spite of various disadvantage from the biological perspective, many metallic implants had been used 
still for bone alternatives. The most commonly utilized metallic implants are stainless steel 316 L 
(ASTM F138), Cobalt based alloys (mainly ASTM F75, and ASTM F799) and titanium alloys. In the 
case of titanium alloys, Ti-6Al-4V (ASTM F67 and F136) are frequently preferred as fixation devices. 
Table – 1.3 provides the list of metallic implants and its corresponding orthopedic applications. 
Table -1.3 Metallic Implants and its orthopedic applications [15] 
METAL IMPLANTS ORTHOPEDIC APPLICATIONS 
Stainless steel (316, 316L) Fracture plates, screws, hip nails 
Co-Cr-Mo alloys Prostheses stems, load bearing positions in total joint 
replacements 
HA coated Ti alloys Hip and knee prostheses, screws and pins for fixation 
Ti6Al4V Prostheses stems 
NiTi Internal fixator for long bone shafts, spinal correctors, vertebral 
spacers anchoring prostheses and staples 
Fabrication of metallic implants and machining according to the required size of the bone defect will be 
a challenging task. Since the biological system demands a porous structure, incorporating porous 
architecture is highly difficult. Due to its ductile nature, metallic implants may tend to get fractured, 
when these metallic materials had been forced to organize itself in a porous architecture. And the 
processing techniques for the fabrication of porous metallic scaffold are also highly complex.  
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This critical situation had catalyzed the search of a new group of materials. In order to solve the 
CSD, it is necessary to optimize the implants from the powder stage itself. Acquiring a desired phase, 
feasibility of machining and achieving desired porous architecture are the major features required for 
repairing CSD. It had been proposed that scaffold based materials are the appropriate bone alternative 
for repairing critical size bone defects [16]. As the inability of metals had been mentioned already for 
this kind of application, it is adequate to utilize scaffolds made of ceramic materials.  
1.4 Bio ceramic implants 
Alumina based ceramics had been recognized as the first bioinert material (refer section 1.3), 
which had been widely used in the load bearing positions due to its better mechanical properties. For a 
better enhancement in mechanical properties, material research professionals had made investigations 
with zirconia, which was also considered as another promising bioceramic material for hip 
replacements. Various bio ceramic materials and its corresponding orthopedic applications had been 
illustrated in table 1.4. 
Table 1.4 – Illustration of bio ceramic materials and its orthopedic applications [15] 
BIO CERAMIC MATERIALS ORTHOPEDIC APPLICATIONS 
Bio inert Materials 
High alumina ceramics Orthopedic load bearing positions 
ISO alumina standard 6747 Dental implants 
PSZ Alveolar ridge augmentation, otolaryngological coatings 
for tissue ingrowth, maxillofacial reconstruction 
Bioresorbable Materials -  
Calcium phosphate cement 
R cement Cleft palate, apical barrier 
H cement Periodontal pockets, filling periapical 
Biopex Alveolar bone augmentation, bony defects 
Bonesource Periodontal osseous defects, repair of large periodefects 
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Table – 1.4 contd. 
BIOGLASSES 
45S5 BG, 45S5.4F BG Maxillofacial reconstruction 
45B15S5 BG Middle ear reconstruction, dental implants 
52S4.6 BG Percutaneous access devices, junction of spinal vertebrae 
GLASS CERAMICS 
KGC ceravital, KGS ceravital, KGy 
213 ceravital 
Dental implants, maxillofacial reconstruction 
AW/GC Vertebral prosthesis devices 
MB GC, Bioverit Iliac crest prostheses 
Apart from these materials, calcium phosphate based ceramics like hydroxyapatite and
β-tricalcium phosphate had been widely preferred for bone repairing applications. These calcium 
phosphate based materials had shown better bioresorbable and bioactivity since they closely resemble 
the mineral phase of the human bone. As alone, these bioresorbable materials were unable to execute or 
take part in the osteoinductive mechanism and also it resorb very slowly. Polymer – ceramics 
bioresorbable composites may reduce this problem by its better degradation, but inducing the osteoblast 
cells will be still slow. It is required to accelerate the bioresorbability process to proceed further with a 
new bone mineral formation. Thus the bioactive materials, which had been categorized under the third 
generation of biomaterials, had been predominantly preferred to carry out tissue regeneration.  
1.5 Polymer based implants 
As the third generation of biomaterials majorly focused on biodegradation and tissue 
regeneration, comparatively biopolymers are the better candidates for biodegradation. A controlled 
biodegradation should be carried out to provide better stability during bone healing. It is necessary 
because scaffolds are not permanent implants. They have to degrade and allow the cells to produce their 
own extra cellular matrix.  In other words, it can be said that degradation rate of the polymers should 
match the neo tissue formation rate [17]. Not all the polymers are biodegradable, at certain times, few 
synthetic polymers exhibit biologically non-degradable behavior.  
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Polymers had been broadly classified as naturally derived polymers and synthetic polymers. 
Most of the natural polymers are biodegradable, like starch, collagen, cellulose and gelatin. Synthetic 
polymers had been sub-classified into biodegradable and non-biodegradable polymers [18].
Table 1.5 illustrates some of the polymers used in bone tissue engineering applications.  
As a single component, polymers fail most of the time due to its low mechanical strength. This 
issue had been solved by using bio ceramic and metal fillers into the polymer matrix. These types of 
design enact the concept of reinforcement to upgrade the mechanical properties of polymer based 
scaffolds. Fig – 1.3 shows illustrates the mechanical properties of different biomaterials used for bone 
tissue engineering applications.    
Table 1.5 – Applications of polymers in bone tissue engineering procedures [15] 
POLYMER MATERIALS ORTHOPEDIC APPLICATIONS 
Polymethacrylic acid 
(PMMA) 
Acrylic bone cements, anchoring of hip prostheses, vertebroplasties 
& kyphoplasties 
Polyethylene (PE) Liner of acetabular cups in hip arthoplasties 
Tibial insert and patellar components in total knee arthoplasties 
Polydimethylsulphoxide 
(PDMS)  
Replacement of small joints in hand and foot 
Polypropylene (PP) Bone fixation devices 
Polysulphone (PS) Bone fixation devices, total joint arthoplasties 
Polycarbonate (PC) Bio absorbable fixation devices and bone regeneration, drug 
delivery 
Polyglycolic acid Bio absorbable fixation devices and bone regeneration 
Drug delivery Polylactic acid (PLA) 
Polycaprolactone (PCL) 
Polydioxanone (PDS) 
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1.6 Bioglass 
1.6.1 Biocompatibility of bioglass  
Prof. L.L.Hench had shattered the concept of bio incompatibility by his revolutionary 45S5 
bioactive glass [12]. It is a glass composition with 45 wt. % of SiO2, 24.5 wt. % of Na2O, 24.5 wt. % of 
CaO & 6 wt. % of P2O5, by which he had strong belief that it has the capability of bonding with the bone 
tissues. By collaborating with Dr. T.K.Greenlee [19], he had conducted in vivo experiments on a rat 
femoral model, which proved the bone bonding capability of 45S5 bioactive glass. Furthermore, they 
had ensured that this 45S5 bioactive glass composition has the capability of forming new bone tissue. 
By invitro analysis, they had clearly confirmed the presence of carbonated hydroxyapatite phase on the 
surface of the 45S5 bioactive glass. The initial intention of Hench and co-workers was to promote the 
bioresorbable behavior of 45S5 bioglass. But their invitro results had clearly proved that the 45S5 
bioglass had the capability to exhibit neo tissue formation. An additional to that, their invitro analysis 
had been undertaken as a complete guide to draft the detailed invitro mechanism of 45S5 bioactive glass 
immersed in Simulated Body Fluid (SBF) [20].  
Simulated Body Fluid (SBF) is an artificially synthesized body fluid, which possesses the close, 
resembles of the ions present in the human body. This ionization reaction had been clearly illustrated in 
the Fig -.1.3. The 45S5 bioglass exhibits SiO2 - CaO - Na2O - P2O5   as its glass system. When the 
scaffolds fabricated based on this glass system, it undergoes around eight steps for the formation of 
carbonated hydroxyapatite phase in invitro SBF medium [21].  
 In the first step, the Na+ and Ca2+ ions had been leached out from the glass composition, which had
been replaced by H
+
 and H3O
+
 ions respectively. Since the ion exchange rate of Ca
2+
 ions will be
comparatively lower than Na
+
 ions, Na
+
 ions degrade first from the glass system. At this situation,
the scaffold will be holding Si-OH, Si-O-Si and Si-O-P as its major bonds.
 The second step of this ionization mechanism will be the attachment of H2O molecules on the above- 
mentioned network. Here these H2O molecules break the Si-O-Si and Si-O-P bonds and forms
completely with Si-OH bonds.
 The excess soluble silanols [Si(OH)4] leached out of the scaffold mixed with the SBF. The breaking
of Si-O-P bonds results with PO4
3-
 ions which go out in the search of Ca
2+
 ions.
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 The fourth step will be the formation of sandwich gel-like structures, which will be in a combination
of soluble silanols and glass with Si-OH bonds.
 This complex structure leads to the initiation of polymerization and condensation of a rich silica
layer with a bunch of Si-OH bonds.
 The next step will be the attachment of Ca2+ and PO4
3-
 ions in a form of clusters. The heavy
deposition of the Calcium Phosphate clusters leads to the breaking of Si-OH bonds of the rich silica
layer.
 Amorphous calcium phosphate (ACP) will be formed when complete silanols had been leached from
the network. Later on OH
-
 and CO3
2-
 ions will get adhered on the surface of the amorphous calcium
phosphate.
 OH- ions hydrate the ACP and CO3
2-
 ions crystallize the same for the formation of carbonated
hydroxyapatite.
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Fig – 1.3 Invitro mechanism of bioglass scaffold in Simulated Body Fluid (SBF) 
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Later on the macrophage cells disseminate the degraded minerals from the scaffolds and the adsorption 
of proteins had been carried out. The next stage will be the attachment and differentiation of stem cells, 
further leads to the HA matrix formation. A cell seeded bioactive glass scaffolds undergoes these 
reaction kinetics. The reaction mechanism will be the same, but the rate of kinetics differs according to 
the crystallinity and density of the bioglass scaffold [22].    
1.6.2 Formulation of Bioglass composition 
Prof. L.L.Hench had been driven by a hypothesis that the implant material along with calcium 
and phosphate minerals would not be rejected by the human body unless it forms a Hydroxyapatite layer 
during in vivo analysis [23]. In order to confirm the hypothesis, L.L.Hench had formulated the 45S5 
glass composition (refer section 1.6.1) by adapting the compositional phase diagram of Na2O-SiO2-CaO 
ternary system (refer fig 1.4). He had utilized a large amount of CaO along with little of P2O5 to blend 
into the Na2O-SiO2 matrix. Apart from this 45S5 glass composition, he had tested bioactivity on various 
other glass compositions which had been illustrated in the fig 1.5. It has to be noted that P2O5 had been 
kept constant as 6 wt. % for all the cases. As shown in the fig 1.5, the glass compositions fall under the 
region A exhibit better bone bonding. Whereas in the case of glass compositions from the regions B,C, 
& D, non-bone bonding had been observed. The reactivity of the glass compositions from the regions B 
& C are too low and too high respectively. But the region D had been filled with non-glass forming 
compositions. The glass compositions from the region S exhibit better bone bonding ability even with 
the soft tissues. These glass compositions can be called as Class A biomaterials. And finally the 45S5 
glass composition had been marked as E. The bioactivity of these glass compositions had been evaluated 
in terms of the index of bioactivity (IB).  The region F represents the Apatite – Wollastonite glass 
ceramic compositions with variable P2O5.     
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Fig – 1.4 Compositional diagram of glass compositions representing bone bonding ability [23] 
Index of bioactivity is the time required for 50% of the implant’s surface to bond bone. By using the 
equation below, all the glass compositions had been characterized [24].  
                       [
   
    
] (      ) 
This evaluation had laid a platform for categorizing the Class A and Class B biomaterials for bone tissue 
engineering applications. From the compositional diagram, it should be noted that not all the glass 
compositions are bioactive materials. Glass compositions with 36wt. % to 52wt. % of silica were 
observed to have better bone bonding ability and falls under Class A biomaterials. Beyond that, the 
compositions will be completely inert and also at certain times they even lose glass forming ability. The 
properties of Class A and Class B biomaterials had been already discussed in section 1.2. But another 
aspect is Class A biomaterials have the ability to bond both hard tissues as well as soft tissues. In the 
case of Class B biomaterials, they have the ability to bond only with hard tissues. Various biomaterials 
and its index of bioactivity had been illustrated in table 1.6.  
Si 𝐎𝟐
CaO 𝐍𝐚𝟐𝐎
A
B
C
D
S
F 
E 
A = bone bonding 
B = non-bone bonding (reactivity too low) 
C = non-bone bonding (reactivity too high) 
D = non-bone bonding (non-glass forming) 
S = Soft tissue bonding 
E = 45S5 Bioglass composition 
F = A/W Glass Ceramic (variable P2O5) 
P2O5 
(6wt.%) 
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Table 1.6 – Biomaterials and its index of bioactivity [5] 
Biomaterial Index of bioactivity (IB) Class of bioactivity 
45S5 Bioactive glass 12.5 A 
5254.6 Bioactive glass 10.5 A 
A/W Bioactive glass ceramic 6 B 
Ceravital glass ceramic 5.6 B 
5554.3 Bioactive glass `3.7 B 
Hydroxyapatite ceramic 3.1 B 
Ceravital K6X 2.3 B 
Alumina 0 0 
In this index of bioactivity evaluation, 45S5 bioglass tops the chart with higher bioactivity and 
acquires the ability to bond both hard and soft tissues. Even though 5554.3 glass composition is also a 
bioactive glass, it acquires low index of bioactivity and had been categorized under Class B 
Biomaterials. This had happened since in its composition it has 55 wt. % of silica, which is not favorable 
as per the compositional diagram (refer fig 1.1). Hydroxyapatite based ceramics has the index of 
bioactivity of 3.1 which is 4 times lower than the 45S5 bioglass, even though HA is the major mineral in 
the bone matrix. This is due to the slow degradation rate of hydroxyapatite which happened due to a 
high percentage of crystallinity. Alumina being an inert material exhibits no bioactivity. Thus bioglass 
(45S5) may be considered as a better bioactive material than any other ceramic materials.     
1.6.3 Synthesis of Bioglass powders 
The traditional approach of preparation of glass powders is the melt quench method. The first 
prepared bioglass powders are also carried out by melt quench method. While L.L.Hench was 
formulating the bioglass composition, he had included Na2O in the 45S5 glass system to reduce the 
melting point of bioglass batch. As the 45S5 glass composition also fell close to the eutectic point, he 
was able to melt the glasses easily.  
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This temperature depends upon the alkali flux used in the glass system like Na2O, K2O and B2O3 
etc. High-quality phosphates, quartz or silica and carbonates are required for the preparation of melt 
derived glasses [25]. Glasses can also be prepared by using sol-gel method. By liquid precursors and 
with a combination of hydrolysis and condensation reactions, sol-gel glass had been prepared. The first 
sol-gel based silica had been synthesized in 1844 by Ebelmen. Commercially, sol-gel coatings to the flat 
glass had been done during the early sixties [26].  Later on, in 1981, ‘the First International workshop on 
glass and ceramics from gels’ had proudly announced the possibility of bioglass synthesis at low 
temperature. Apart from low-temperature synthesis, high homogeneity, high purity and short range of 
particle size are the other advantages of this method.  
The major differences acquired between sol-gel derived glasses and melt quench glasses are the 
surface area and porosity rate of the glasses, in general, the textural properties [27]. The surface area of 
sol-gel derived glasses will be high when compared to the melt quench glasses. Apparently the particle 
size of the melt derived glasses will be in micron range whereas in the case of sol-gel glasses, it will be 
in the nano range. These changes majorly influence the biological properties by expecting higher ionic 
exchange with sol-gel derived glasses than the melt derived glasses. Kinetically this leads to rapid 
formation of larger amount of apatite layer in sol-gel derived than the melt derived glasses. In spite of 
various advantages of sol-gel glasses over melt derived glasses, melt derived glasses had been preferred 
due to its low-cost raw materials and feasibility for bulk production.   
1.6 Scaffold architecture 
The self-assembly technique of skeletal tissues, namely the bones and cartilages, leads to the 
formation of 3D skeletal structural framework [28]. In order to repair complex bone fractures or any 
other bone based disorders, it is necessary to obtain a scaffold, whose architecture has to be optimized 
into 3D structural units. Since the anatomy of bone represents itself as a highly vascularized porosity 
gradient structure, the implant material should mimic the same to attain better growth mechanism and 
bone healing. This can be possible only with the 3D scaffolds which had been widely accepted during 
the discovery of bioglass itself.  Thus, the entire field of bone tissue engineering broadly relies on the 
usage of porous 3D scaffolds for better proliferation. From the material scientist’s perspective, scaffolds 
are supporting structures, with optimized 3D architecture, which take part in bone healing mechanism. 
But in a biological perspective, scaffolds can be called as templates, where cells had been seeded, which 
facilitate tissue formation on it [29].  
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Occasionally along with cells, growth factors are also incorporated into the scaffolds, which 
enhance tissue regeneration. These mechanisms will be successfully carried out unless and until proper 
diffusion of biological fluid and cell viability took place. For better diffusion and cell viability, it is 
necessary to provide optimum pore size with interconnected pore structure to the scaffolds. The 
osteoinducible minerals from the biomaterial scaffold degrade and structural minerals from the scaffold 
will get stimulated to form new bone [30].  
The biomaterial 3D scaffold should exhibit a controlled rate of degradation to execute these 
mineral exchange mechanisms successfully. This partly depends on the strength of the scaffold, i.e. the 
elastic modulus of the material utilized for scaffold fabrication. Different regions of the body demand 
scaffolds with different elastic modulus. Verifying the elastic modulus had been considered as one of the 
major criteria for material selection. Most of the cells, excluding the blood cells, reside as a solid matrix 
in the extra cellular matrix; the scaffolds have to contribute some mineral phase to it, which facilitates 
better bioactivity. Thus, the composition of the biomaterials used for scaffold fabrication plays a vital 
role in this mineral phase formation during bone remodeling. The biomolecules recognize these 
biomaterials as a foreign body and the level of toxicity varies according to the biocompatible properties 
of the scaffolds. By consolidating the above-mentioned facts, it had been realized that more 
investigations are required to analyze the chemistry of biomaterials. In short, including the architecture 
of the scaffold, the mechanical and biological properties have to be optimized to fabricate an ideal 
scaffold [31]. C.M.Agarwal et al [32] had clearly drafted the desirable properties of an ideal scaffold as 
follows:  
1. Biocompatible in nature
2. Biodegradable and ability for remodeling
3. Biodegradability should be along with the repairing/regenerative process
4. It should contain optimum amount of porosity with interconnectivity
5. It should have high permeability to allow proper diffusion of biomolecules
6. Pore size should be comfortable for the encroachment of target cells
7. Adequate mechanical properties to establish micro stress environment for cells
8. Scaffold surface properties should enhance affinity of cell attachment
9. Contribution of subsequent minerals to ECM
10. It should be capable of carrying the growth factors
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1.7 Significance of Functionally graded biomaterials 
As discussed in section 1.1, functional gradation had been evolved within the bone tissue 
morphology. To be more specific, the gradient in porosity had been attained from the cortical bone to 
the cancellous bone layers. These pores are highly responsible for the attachment of extra cellular 
matrix, spreading of cells within the interconnected pore network and differentiation of cells. These 
mechanisms are the essential modules of tissue regeneration. Customized pore size and pore 
morphology acquires better cell affinity and viability. It can be concluded that mimicking or simulating 
the bone morphology into the scaffold design favors the enhancement of tissue regeneration. An 
additional to that several researchers had reported that the fractures of homogeneous scaffolds had been 
more viral than the fractures occurred in porosity gradient scaffolds. Thus, the fabrication of porosity 
gradient scaffolds will be highly inspired by the grafting area.     
1.8 Scope of work 
The above-mentioned facts clearly illustrate that bioglass is the better bioactive material than any 
other ceramic materials (refer table 1.6). It had been clearly understood that scaffold based materials 
are the better solution for critical size bone defects. Since bones possess porosity gradient structure 
(refer fig 1.1), it is required to achieve a porosity gradient structure in the scaffold architecture to attain 
better biological recognition. Thus it had been concluded that bioactive glass-ceramic scaffolds have to 
be designed with porosity gradient architecture (refer section 1.6). These porosity gradient bioglass 
scaffolds may enhance better tissue regeneration and most importantly, they heal the critical size bone 
defects.  
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2.1 Design of Tissue Engineered Scaffolds 
 Till now, the protocols of implant devices drafted by the material scientist and research 
professionals commenced with a module called ‘selection of biomaterials’. A better understanding of the 
properties of biomaterials and its appropriate correlation with the clinical principles is required, which is 
considered as a prime factor in the entire design process. Felicity R. A. J. Rose et al [33] had given a 
better review about the strategies of tissue-engineered scaffold. The clinical needs, stem cell 
differentiation in a scaffold and growth factors are the major concepts discussed which completely rely 
on the architecture of the scaffold. His review highlights the significance of an osteoconductive and 
osteoinductive scaffold, which furthermore opens the gateway for angiogenesis*.   
 The scaffolds with porous architecture favor the angiogenesis had been observed by Kuboki Y et 
al [34]. They carried out experiments for Bone morphogenetic proteins (BMP-2) delivery to a rat ectopic 
model. A mixture of a solid and porous form of hydroxyapatite had been used for BMP delivery. No 
new bone had been formed in the dense regions whereas perfect osteogenesis* had been carried out in 
the porous regions.  This gives the clear picture about the significance of porous scaffolds for bone 
tissue engineering applications.  
 As bone is already porosity gradient in structure (section 1.6), incorporation of optimum porosity 
on the scaffold paves the way for the biomimetic approach. Various fabrication techniques had been 
designed and executed by many people for porous materials. But all the techniques will have its own 
limitations on the optimization of pore morphology. A simple review had been given by Julian R. Jones 
& Larry L. Hench [35] about the regeneration of trabecular bone, i.e. the porous regions of a scaffold 
material.  Direct foaming, with porogens, gel casting, sol-gel method, polymer replica and rapid 
prototyping are the methods had been discussed in that paper. Each method provides different pore 
morphology and pore size. They had concluded that complete biological characterization has to be 
carried out to understand the detailed invitro mechanism on the variation of pore morphology.  
 Fabrication technique of porous scaffolds, shape, pore size, porosity (%) and its corresponding 
appropriate biological application had been illustrated in the review of David Kaplan et al [36] and had 
been adapted here in the table 2.1 to 2.6. 
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Table 2.1 - Porosities and pore size of bio ceramic scaffolds – adapted from David Kaplan et al [36] 
Material Fabrication 
technique 
Shape Pore size(μm) Porosity 
(%) 
Biological Application 
 
 
 
 
 
 
 
 
Hydroxyapatite 
10(HAP) 
 
 
 
 
 
 
 
 
Sintering 
Scaffolds with honey 
comb pores 
90-120, 100-200 and 
350 
 BMP-2 delivery & ectopic 
bone formation in rats 
 
Scaffolds 366 and 444 38 & 44 Mandible defects 
 
Scaffolds 400 and 800 60 & 70 Goat bone marrow stromal 
cells ex-vivo and ectopic 
bone formation in goats 
 
Blocks 500 77 Ectopic bone formation in mice 
    
Cylinders 400- 600 80 Femoral defects in rats 
 
Blocks 100-200  BMP-2 delivery & ectopic 
bone formation in rats 
 
Blocks 106–212, 212–300, 
300–400, 400–500, 
and 500–600 
 
 Ectopic bone formation in rats 
Particles 150 & 230 70 & 66 
 
 
Rods 200 and 400  Ectopic bone formation in dogs 
Tricalcium phosphate 
(TCP) cement 
Salt leaching Pellets 0.2 and 8.7 31 & 62  
Calcium 
metaphosphate 
 
Sintering 
 
Blocks 200  Rat bone marrow stromal cells 
ex-vivo and ectopic 
bone formation in goats 
Natural coral Sintering Human mandibular 
condyle 
150-200 36 Rabbit marrow mesenchymal 
cells ex vivo andectopic bone 
formation in mice 
HAP/TCP Sintering Blocks 100-150 36 Femoral defects in dogs 
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Table 2.2 - Porosities and pore size of glass and glass ceramic scaffolds -                                            
adapted from David Kaplan et al [36] 
Material Fabrication 
technique 
Pore size(μm) Porosity 
(%) 
Biological Application 
Glasses sintering 100 – 200 5  
   40 Tibia defects in rabbits 
Bioglass Foaming 10 – 500  Primary human osteoblasts in vitro 
 
 Sintering 100 – 600  Ectopic bone formation in dogs 
Glass ceramics Sintering 
 
100 – 200   
 Phase 
transformation 
10 – 300 51, 47 & 
43 
Femoral defects in rabbits 
 
 
 
 
Table 2.3 - Porosities and pore size of natural polymer scaffolds –  
adapted from David Kaplan et al [36] 
Natural polymer Fabrication 
technique 
Pore size(μm) Porosity 
(%) 
Biological Application 
Hyaluronic acid Salt leaching 100 – 600 80 – 90 BMP-2 delivery and 
C3H10T1/2 cells in vitro 
Collagen Freeze drying 11-105 & 
14-134 
 Tibia defects in rats 
 
Collagen / Hyaluronate Cross linking 45.7 & 35.4  Cranial defects in rats 
Collagen / Hyaluronic 
acid (cross linked with 
EDC) 
Freeze drying 84 (-196°C) 62(-196°C)  
  186(-70°C) 62(-70°C)  
  190(-20°C) 64(-20°C)  
Silk fibroin Freeze drying 50(-20°C) 99  
  15(-80°C) 
 
  
 Salt leaching 202 84 – 98 Human bone marrow 
stromal cells in vitro 
 
 Gas foaming 155 87 – 97  
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Table 2.4 - Porosities and pore size of metallic scaffolds for bone regenerations -                            
adapted from David Kaplan et al [36] 
Porous surface technique Pore size(μm) Porosity 
(%) 
Biological Application 
 
Sintered titanium fiber 
meshes 
 
250 
 
86 
 
Rat bone marrow stromal cells ex vivo 
and cranial defects in rats.  
   TGF-b1 delivery in cranial defects in 
rabbits 
 
Self-propagating high 
temperature synthesized 
nitinol implants 
 
259 and 505 
353, 218 & 179 
 
66 and 47 
43, 54 & 51 
 
Femoral defects in rats 
Cranial defects in rabbits 
Sintering 50-200 35  
Plasma spraying 200- 400 50 - 60 Femoral defects in dogs 
  56 - 60 Femoral condyles in dogs 
Diffusion 350 45 Hip arthoplasties in dogs 
Laser texture 100, 200 & 300  Femoral defects in rabbits 
Electrochemical oxidation < 8 13 – 24 Tibia defects in rabbits 
Machining Submicron to 10   
Shot blasting < 10 44 and 48 Mandible and femoral defects in dogs  
Acid etching Submicron to 1  Femoral defects in rabbits  
Deposition through 
polystyrene latex beads 
0.4, 13 and 40  Human bone derived cells in vitro 
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Table 2.5 - Porosities and pore size of chemically synthesized polymer scaffolds - adapted from David Kaplan et al [36] 
Polymer Fabrication technique Pore size (μm) Porosity (%) Application 
Poly(lactide) Salt leaching 600   
Poly(lactide) / Poly(glycolide) Molding 800   
Poly(L-lactide-co-D, L-lactide) Porogen melting  58 and 80  
Poly (lactide-co-glycolide) Sintering 72, 164, 101 
and 210 
>30  
 Consolidation by pressure 
drop 
100 65 Teeth implants 
 Sintering 187 31  
 Gas foaming 200  Human mesenchymal stem cells in 
vitro 
 Electros pining 2 – 465 92  
Poly (lactide-co-glycolide) /     
Poly (ethylene glycol) 
Porogen dissolving 300 – 500 `85 Periosteal cells in vivo 
Poly (lactide-co-glycolide) /    
Poly (vinyl alcohol) 
Salt leaching 200 – 300 90 Cranial defects in rabbits 
Poly (multifunctional lactic acid 
based oligomer) 
Salt leaching 45 – 150 and 
300 – 600 
80  
Poly (propylene fumarate) Gas foaming with 
effervescent reaction              
(in vivo) 
70 51 Tibia defects in rats 
 Salt leaching 300 – 500 70 TGF – β1 delivery in cranial defects in 
rabbits 
 Salt leaching  80  
 Salt leaching 300 – 500 and 
600 – 800 
57 – 75 Cranial defects in rabbits 
Polyethylene terephthalate Melt – blowing  93 – 97 Rat mesenchymal stem cells in vitro 
Polymeric foams Emulsion polymerisation 40 and 100  Rat osteoblasts in vitro 
Poly (glycol-co-fumaric acid) Gas foaming with 
effervescent reaction              
( in vivo) 
100 – 500  Cortical defects in rats 
Poly(desaminotyrosyl-tyrosine 
ethyl ester carbonate) 
Salt leaching 500 80 – 87.5 
(gradient) 
Cranial defects in rabbits 
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Table 2.6 - Porosities and pore size of composite scaffolds - adapted from David Kaplan et al [36] 
Composite Fabrication technique Pore size (μm) Porosity (%) Application 
Hydroxyapatite /     
poly (ε caprolactone) 
Sintering 150 – 200 87 
Hydroxyapatite /  
chitosan – gelatin 
Freeze drying 300 – 500 Rat calvarial osteoblasts in 
vitro 
Hydroxyapatite / β – TCP / 
chitosan 
Sintering 300 – 600 
Collagen / hydroxyapatite Freeze drying 30 – 100 85 Rabbit periosteal cells in 
vitro 
Freeze drying 50 – 300 49, 73 and 79 MC3T3- E1 osteoblasts in 
vitro 
Titanium / calcium 
phosphate 
Sintering 50 – 200 (surface coating) 35 (surface coating) Femoral defects in rabbits 
Sintering 250 (porous meshes) 86 (porous meshes) Ectopic bone formation in 
rats 
Soaking Human osteoblasts in vitro 
Titanium / polyvinyl 
alcohol (PVA) 
Sintering 170 60 Femoral condyles in dogs 
Titanium / boron Self-propagating high 
temperature synthesis 
15 – 55 Cranial defects in rats 
Poly(L-lactide-co-D, L-
lactide) / β – TCP 
Salt leaching 125 – 150 80 – 87.5 (gradient) Cranial defects in rabbits 
Poly(propylene fumarate) / 
β – TCP 
Salt leaching 150 – 300 69 and 74 
Poly(L-lactide)/bioglass Phase separation 50 – 200 
silica / ceramic Sintering 10 – 300 51, 47 and 43 Femoral defects in rabbits 
Poly(lactide-co-glycolide)/ 
collagen/apatite 
Salt leaching 325 – 425 87 
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The table 2.1 to 2.6 reveals that each fabrication technique fetches different pore morphological 
parameters.  Each grafting site demands different pore morphological specifications. The biomimetic 
approach of designing a tissue engineered scaffold becomes very complex due to these kinds of clinical 
facts. Apart from the scaffold architecture, surface chemistry, biodegradation mechanism, leached out 
mineral phases, regenerative capability and the mechanical properties of the scaffolds are the major 
challenges which have to be investigated for fabrication of an ideal scaffold.    
2.2 Bioactive glass / glass ceramic based scaffolds 
Bioactive glasses had been in demand as a scaffold material due to its high bioresorbability and 
regenerative capability. It had been widely accepted that scaffolds fabricated with bioactive glasses had 
a pronounced effect in stimulating the osteogenesis at genetic level [37]. In another perspective, the 
dissolution rate of amorphous materials will be high when compared with crystalline material: 
Rate of dissolution of Amorphous HAP >> α – TCP >> β – TCP >> crystalline HA [38] 
The above statement can be generalized and it can be concluded that rate of dissolution of bio-glasses 
will be more than the synthetic hydroxyapatite and other crystalline materials. This means the 
regenerative capability of bioactive glasses is higher than not only with hydroxyapatite but also with 
other biomaterials. Bioactive glasses had been synthesized by the conventional melt quench method and 
sol-gel method [39-43]. Due to the mesoporous structure of sol-gel derived glasses, they are highly 
bioactive than the melt quench glasses [44] But the necessity of preferring melt derived glasses had been 
briefly explained in the section 1.6.3. 
As L.L. Hench et al discovered 45S5 bioglass on 1978 [45], many material scientists started 
designing scaffolds with various bioactive glass compositions. The emergence and necessity of scaffolds 
too got highlighted only after the discovery of bioglass. It had been observed that bioglass possess poor 
mechanical property. Meanwhile by pronounced heat treatment, which by default incorporates 
crystalline phases, enhances the mechanical properties. The early research papers of L.L.Hench had 
discussed regarding this issue. Therefore, selection of a fabrication technique and optimizing better 
powder characteristics (starting material) are much important. Sol-gel processing, thermally bonding of 
particles or fibers, polymer foam replication, solid free form or rapid prototyping and freeze casting are 
some of the methods followed for the fabrication of bioactive glass scaffolds [46].  
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Comparatively, better mechanical strength had been attained in most of the bioactive glass 
compositions than the biodegradable polymers [47]. Better mechanical properties of bioglass based 
scaffolds can be attained unless and until sintering has been done at higher temperatures. Sintering 
beyond the glass transition temperature leads to the formation of glass ceramic phases, which actually 
makes the scaffold inert [48]. But later on, Oscar P.F. et al [49] had observed with their 45S5 bioglass 
ceramic scaffolds, that bioactivity is restricted and not completely suppressed, due to crystallinity. Due 
to this ambiguous situation prevailed within the crystallization and mechanical properties of bioglass 
scaffolds, fabrication of bioglass based composites had been started. The approach towards the 
fabrication of bioglass based scaffolds had been varying in a wide range due to its capability of attaining 
tailored properties. Francesco Baino et al [50], in their review, had described different methods used for 
the preparation of bioglass based scaffolds, till date. The entire description had been depicted in
table 2.7.    
R. Boccaccini et al [51] had fabricated porous 45S5 bioglass scaffolds by using sponge replica 
method. By dipping polyurethane foams in melt-derived bioglass slurry, the scaffolds had been 
fabricated and sintered at around 1000°C/1 hour. At around 89-92% of porosity and 0.42MPa of 
compressive strength had been obtained with these scaffolds. Keeping the trabecular bone regions in 
mind, this work had been executed.  
Table 2.7 – Processing methods for the fabrication of bioactive glass based scaffolds [50] 
S.No Processing method Description 
1. Coating methods It provides a bioactive layer on the substrate of the major 
implant material. It is carried out from the suspensions of 
bioactive glass particulates. Thermal treatment is not applied 
to remove the organic phase. Sintering is not done for the 
densification of inorganic phase.  
2. Evaporation induced self-assembly 
[EISA]  
This method offers mesoporous silica based glasses. With the 
metal alkoxide liquid precursors, surfactant is added for better 
solvent dispersion. Evaporation of ethanol increases the 
concentration of surfactant. Further the surfactants drive the 
silica molecules to organise into a mesophase structure. 
Calcination burnouts the surfactant and generate mesoporous 
glasses.  
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Table – 2.7 continued. 
3. H2O2 foaming Bioactive glass powders and H2O2 solution is mixed 
homogeneously and the solvent had been casted into moulds. 
The casted bodies had been dried at 60°C in a dry air owen 
and foams had been generated. Further sintering of those 
casted bodies forms porous scaffolds.  
4. In-situ foaming Sol-gel derived bioactive glass powders had been dispersed in 
liquid monomer batch. After polymerisation took place, 
sintering of glass particles had been carried out.   
5. Microsphere sintering Glass polymer microsphere composites had been prepared by 
evaporation of emulsion solvent. Sintering of those 
microspheres results with porous 3D bioglass scaffolds 
6. Organic phase burn out Bioactive glass powders had been mixed with organic 
polymers, either binder or pore formers, had been compacted 
with some optimum pressure and sintered at some optimum 
temperature.  
7. Sol gel method This method is a combination of hydrolysis and condensation 
reactions. With metal alkoxide liquid precursors, glass 
formation had been carried out at low temperatures. Glass 
monoliths and coatings can be done with this method. 
Furthermore, production of glass nanomaterial can be done by 
this method.   
8. Sol gel foaming Similar to the previous method, synthesis had been carried out 
liquid precursors. In additional to that, surfactants had been 
included for the formation of foams. Generated foams had 
been sintered for the formation of porous scaffolds.  
9. Solid free form fabrication As per the computer aided design, 3D printing of scaffolds 
had been done. 
10. Solvent casting – particulate leaching Polymer solution had been prepared and salt particles had 
been added into it. Bioactive glass particles had been added 
later and casted into moulds. On drying the solvent evaporates 
and leaves the salt behind. On treating them in a bath makes 
the salt particles to get leached out and leaves a porous 
structure.  
As bioglass scaffolds degrade in a controlled manner, the targeted oxides, which had been 
incorporated into the glass system for a particular purpose, will release as metals ions and performs its 
function. The feasibility of tailoring a biomaterial is more in the glass system when compared to the 
other biomaterials.  
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2.3 Functionally graded scaffolds (FGS) 
Identification of a utility of FGSs in the field of biomaterials is entirely a new scenario. The 
necessity of FGSs in the biological systems is purely of the responses stimulated by the morphology of 
the living tissues. The prominent and remarkable feature of biomaterials in invitro is the tendency to 
form hierarchical structures. The pathways of the cells and other micro fluids of biological systems are 
habituated with the hierarchical structures [52]. In order define the fabricated scaffolds as biomimetic 
scaffolds, and then it is necessary to obtain hierarchical architectures for the scaffolds. In the previous 
sections, it had been discussed that bone is a functionally graded material, with dense-cortical bone layer 
and porous – cancellous bone layer, which is the outer and inner layers of the bone respectively. Better 
bone ingrowth had been facilitated in the porous regions and dense regions restrict the physiological and 
mechanical stress generated within and surrounding the host tissue [53]. So, in particular, it is necessary 
to fabricate scaffolds with a porosity gradient structure to mimic the natural bone architecture. 
Cevat Erisken et al [54] had fabricated functionally graded Polycaprolactone/β-TCP 
nanocomposite by using twin screw extrusion/electrospining process. This polymer blend had been 
incorporated along with β-TCP to mimic the bone and cartilage interface. The spatial distribution of 
calcium phosphate phase and organic polymer phase increases the feasibility of better proliferation of 
the osteoblast cells.     
 Young-Mi Soon et al [55] went beyond further for the reproduction of cortical/cancellous bone 
structure. In a material science perspective, it can be called as core and shell structures. Their scaffolds 
had been fabricated by using Camphene based freeze casting method, with different concentrations of 
hydroxyapatite slurries. The slurries had been casted on a graphite template and further it had been fired 
around 900°C for the removal of the same. Then the dried core/shell green structures had been sintered 
at around 1250°C. It had been observed that compressive strength of core/shell HA scaffolds is better 
than the ordinary porous (non-graded) HA scaffolds. Similar camphene based free casting method had 
been utilized by Changqing Hong et al [56] for fabrication of functionally graded alumina ceramics. 
Here slurries had been casted in silicone rubber die instead of graphite template.  
Each layer of FGS possesses different characteristic features and can be fabricated individually. 
Y. H. Hsu et al [57] had fabricated cortical bone layer and cancellous bone layer separately and joined 
together.  
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Low porosity layer had been fabricated by vacuum impregnation method whereas high-porosity layer 
had been fabricated by using dipping method. Both of the microstructures partly depend on the 
templates used. Later on, both the layers had been joined by using press-fitting method.  Illustration of 
this method had been given in the Fig – 2.1. .  
Fig –2.1 Illustrations of cortical-cancellous bone layer fabrication [Y. H. Hsu et al] 
Gradient structures can also be generated by using a mixture of powders with different particle size. 
L.H.Wong et al [58] had prepared Fluoroapatite and TCP on different particle sizes. Their investigations 
reveal the comparative study of symmetric and non-symmetric FGM on before and after sintering. This 
had been clearly visualized in Fig – 2.2. In this work, the differential shrinkage had been considered as a 
major problem.  
Fig – 2.2 Change in shape after sintering due to differential shrinkage (a) Non-symmetric FGM 
(b) Symmetric FGM  [L.H.Wong et al] 
(a) High porous –spongy bone by dipping method 
(b) Low porous – cortical bone layer by vacuum impregnation method 
(c) Joined cortical and spongy bone layers by press-fitting method  
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Chiara vitale-brovarone et al [59] had fabricated porosity gradient bioglass ceramic  scaffold to 
mimic the cortical and cancellous bone structure. SiO2(45 wt.%) – P2O5 (3 wt.%) – CaO (26 wt.%) –
MgO (7wt.%) – Na2O (15wt.%) – K2O (4wt.%) glass system had been in this work, which is 
commercially called as  CEL2 glass. For the processing of this FG-glass ceramic scaffold, they had 
proposed six methods ( refer Fig – 2.3) and its features had been illustrated in the table – 2.7.  
Table – 2.8 Characteristic feature of CEL 2 glass ceramic – porosity gradient sacaffold [59] 
Method Preparation details Scaffold structure Coresspondence with 
the human bone 
A PE burn-off Multilayer structure Cancellous bone 
B PE burn-off + glazing technique Porous layer +compact layer Cancellous/ cortical bone 
C Sponge replication Porous double layer Cancellous bone 
D Sponge replication + glass 
powders pressing 
Porous double layer + 
compact layer 
Cancellous/ cortical bone 
E Sponge replication + glazing 
technique 
Porous double layer + 
compact layer 
Cancellous/ cortical bone 
F Sponge replication + PE burn-
off 
Porous double layer Cancellous bone 
S-CEL2 Sintering of glass powder 
compacts 
Bulk Cortical bone 
Fig – 2.3 Features of the proposed methods for the fabrication of FGS [59] 
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Jan Wernera et al [60] had developed graded HA matrices by multiple tape casting method as 
shown in the Fig – 2.4. Along with HA slurry, polybutylmethacrylate spheres, of diameters ranging from 
100-200mm and in further heat treatment, leaves a pore size of about 70-200mm. The sintering 
temperature is the major criteria which influence more on the density and microstructure. It had been 
observed that a three-layer graded porous structure attains flexural strength higher than the 
homogeneous porous structure.  
Fig – 2.4 Hydroxyapatite based FGS by multiple tape casting method [60] 
2.4 Concluding Remarks from the literature 
On the above findings from the literature, it can be observed that the fabrication of porosity 
gradient – functionally graded scaffold will fetch the exact architecture of the natural bone. Various 
processing techniques for the fabrication of functionally graded scaffold had been summarised in the 
above mentioned literatures. A distinct boundary conditions for the cortical and cancellous bone layers 
has to be applied in order to mimic the exact nature of the bone, which had not been optimized yet in the 
FGS design. The current work had been capitalised more on this problem, which had been tried to 
overcome by the uniaxial die pressing method. Morever, fabrication of functionally graded glass 
scaffolds are attempted by very few people. Its well known that FGS will create an exact mimicking of 
the biomodal structure of bone. Further more, FGS designed with glass materials fluorish more with an 
enhanced bioactivity, since these glasses topped the chart of index of bioactivity (refer table – 1.6).    
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OBJECTIVE OF THE CURRENT WORK 
Functionally graded scaffolds (FGS) prepared with Class A biomaterials can be the better alternative for 
bone substitutes. It is evident from the literature that the fabrication of functionally graded scaffolds had 
been carried out with highly complex protocols. It is necessary to propose a simple method for the 
fabrication of functionally graded scaffolds. In this current work, bioactive glass compositions 45S5 
(6wt. % P2O5), 2P (2wt. % P2O5) and 4P (4wt. % P2O5) had been taken for the fabrication of 
functionally graded scaffolds. The compositions of these bioactive glasses had been illustrated in the 
table given below  
BIOACTIVE 
GLASS 
    
(in wt%) 
     
(in wt%) 
   
(in wt%) 
    
(in wt%) 
45S5 Bioglass 45 24.5 24.5 6 
2P 49.6 24.2 24.2 2 
4P 48.4 23.8 23.8 4 
But it is necessary to evaluate the performance of single layer scaffolds, before fabrication of 
functionally graded scaffolds. The featured investigations in this work had been designed as follows: 
 Synthesis of bioactive glass compositions – 45S5, 2P and 4P by melt quench method.
 Study of thermal analysis and sintering behavior of Bioactive glass compositions
 Study of phase Analysis and FTIR analysis of bioactive glass and glass ceramics
 Haemocompatibility, protein adsorption and cell viability studies on bioactive glass and glass
ceramics
 Fabrication of porous single layer bioactive glass ceramic scaffolds, incorporating naphthalene as a
pore former, by using uniaxial pressed and sintering method
 Evaluation of Apparent Porosity, Bulk density, Diametral tensile strength & Flexural strength of
porous single layer scaffolds
 Microstructure analysis of single layer – porous bioactive glass ceramic scaffolds
 Fabrication of porosity gradient bioactive glass ceramic scaffolds, incorporating naphthalene as a
pore former, by uniaxial pressed and sintering method
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 Evaluation of Apparent porosity and bulk density of entire FGS and layer by layer
 Brazilian disc analysis of functionally graded bioactive glass ceramic scaffolds
 Microstructure analysis of functionally graded bioactive glass ceramic scaffolds
 Invitro analysis of functionally graded bioactive glass ceramic scaffolds by using Simulated Body
Fluid (SBF).
 Invitro analysis of functionally graded bioactive glass ceramic scaffolds by using MG-63 cell line.
  
 
CHAPTER 3  
EXPERIMENTAL PROCEDURE 
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3.1 Bioactive glass composition and raw materials 
The evaluation and performance of bioactive glasses mentioned in the SiO2-CaO-Na2O ternary 
phase diagram (refer fig – 1.4) had been carried out by keeping P2O5 as 6 wt.%. This had triggered to 
initiate the work by analysing bioactive glass compositions with varying wt.% of P2O5. The glass 
compositions selected in this current work had been given in table 3.1. The glass composition with 2 
wt.% of P2O5 had been identified as 2P and similarly the glass composition with 4 wt.% P2O5 had been 
called as 4P.  
Table 3.1 – Bioactive glass compositions used 
BIOACTIVE 
GLASS 
    
(in wt%) 
     
(in wt%) 
   
(in wt%) 
    
(in wt%) 
45S5 Bioglass 45 24.5 24.5 6 
4P [61] 48.4 23.8 23.8 4 
2P [61] 49.6 24.2 24.2 2 
In order to synthesize bulk and economic bioactive glass powders, melt quench route had been selected. 
The extra pure silica (40-150 mesh) - SiO2, precipitated Calcium Carbonate (AR) – CaCO3 and 
Anhydrous Diammonium Hydrogen Orthophosphate – (NH4)2HPO4, purchased from Loba Chemie, 
Mumbai, India, had been used as raw materials for SiO2, CaO and P2O5 in the glass system. Anhydrous 
Sodium Carbonate (AR), procured from RFCL, is used as a source for Na2O. As mentioned in section 
1.6.3, these raw materials are cheaper than the precursors used for sol-gel method.  
3.2 Preparation of glass powders by melt quench method 
Without further processing of raw materials, as per the batch calculation, the raw materials had been 
weighed and mixed homogeneously. The above mentioned glass compositions (Table-3.1) had been 
melted in sillimanite crucible as per the optimised melting profile shown in Fig 3.1. At 650°C, the glass 
batch had been soaked for 1hour and proceeds further to the decarbonation stage at 950°C. For the 
decomposition of carbonates present in Anhydrous Sodium Carbonate and Calcium Carbonate, the glass 
batch had been soaked for 5 hours at 950°C.    
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Fig 3.1 – Melting profile of bioactive glasses 
Fig – 3.1 Melting profile of Bioactive glasses 
Fig – 3.1 Melting profile of bioactive glasses 
The next soaking cycle had been carried out in the melt initiation stage at 1200°C for 2 hours. Finally, 
the glass batch had been melted at 1450°C for 4 hours. Sufficient holding time has to be provided at 
1450°C to attain better homogeneity of the melt. Then the glass melt had been poured in a water bath for 
the formation of glass frits. The glass frits had been milled by using planetary milling with Silicon 
Nitride balls on a silicon nitride milling jars in a deionized water medium. The obtained glass frits had 
been milled for 8 hours at 350 rpm to make them into powder. Further, the powders are again milled for 
13 hours at 380 rpm. 
3.3 DSC-TG Analysis of Bioactive glass powders 
Thermal Analysis of the bioactive glass powders had been carried out by using Netzsch 
STA/409C. Both Differential Scanning Calorimetry and Thermogravimetric analysis had been done with 
this equipment. The glass powders had been fired from room temperature to 950°C in Argon 
atmosphere. Heat flow (mW/mg) and Mass loss (%) had been observed with the corresponding 
temperature.   
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3.4 Dilatometric analysis of Bioactive glass samples 
Sintering and shrinkage behavior of the bioactive glass green compacts had been studied by 
using NETZSCH dilatometer model DIL 402 C. Bar shaped (15mm x 6mm x 6mm) bioactive glass 
green compacts had been used for this investigation. The sintering and shrinkage behavior had been 
observed by firing the samples from room temperature to 900°C at a heating rate of 10°C/min, in Argon 
atmosphere.   
3.5 BET surface area analysis 
The Brunauer–Emmett–Teller (BET) surface area had been measured by using 5 point method 
analysis had been done by AUTOSORB 1, (Quantachrome) (Model No: Nova 1200 BET). The BET 
method is carried out by using monolayer of liquid nitrogen. The surface area had been calculated by 
using the following equation, which actually required the amount of nitrogen absorbed. 
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3.6 Cell Viability analysis of bioactive glass powders 
Before designing and fabricating scaffolds, it is necessary to check the level of toxicity of the 
biomaterial used. The cytotoxicity analysis had been done on bioactive glass powders and bioactive 
glass ceramics (heat treated at 800°C, 850°C and 900°C) with MG-63 osteoblast cell line. The cell line 
had been procured from NCCS, Pune, India and the entire  investigation had been carried out in the 
Department of Biotechnology & Medical Engineering, NIT Rourkela. The cells had been seeded, at a 
concentration of 10
4
 MG-63 cells per well,  along with 200 µl of Dulbecco’s Modified Eagle Medium
(DMEM), Himedia (high glucose), on a 96 well plate. The cell seeded well plate had been kept for 
incubation(5% CO2 + 95% Humidity @ 37.5°C) for 1 day, in a CO2 incubator for cell adherence.   
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10mg of bioactive glass and glass ceramic powders had been sterilized by heating at around 121 °C in an 
autoclave, at 15 psi pressure for 20 minutes. Then the sterlized glass and glass ceramic powders had 
been dispersed in a Phosphate Buffer Saline(PBS), Himedia, at a ratio of 1:9 [62]. After the cells had 
been adhered on the surface of the wells, the media had been removed from the wells. The 10µl of PBS-
glass and 10µl of PBS-glass ceramic powder mixture had been added to the wells along with 190µl of 
fresh DMEM, had been kept for incubation.  
Fig – 3.2 Formation of Farmazon compounds during mitochondrial reduction 
After 1 day incubation, the media (along with PBS-glass/glass ceramic mixture) had been removed from 
the wells. Then 1µl of MTT Assay, Himedia, and 9µl of DMEM added to the wells. MTT Assay is a 
complex bromide compound which undergoes mitochondrial reduction  reaction with the viable cells 
present in the well, as shown below. During this reaction, viable mitochondria crystallizes the MTT, 
which leads to the formation of farmazon compound. The farmazon is an insoluble purple color 
precipitate which had been dissolved by Dimethyl sulfoxide (DMSO), Sigma Aldrich, Reagent Grade, 
99%. The optical density of farmazon compound will be directly proportional to the cell viability. This 
had been evaluated by using Double beam UV Spectrophotometer, Systronicx 2203, by measuring the 
absorbance at 595nm [63].     
FARMAZON 
Mitochondrial Reductase 
MTT ASSAY 
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3.7 Protein Adsorption Studies of Bioactive glass powders 
To attain better proliferation, protein absorption has to be carried out by these bioactive glass 
scaffold. While incorporating outer collagen layer to the bioglass scaffold, this protein adsorption 
studies plays the major role. 
Fig – 3.3(a) Bioactive glass powders mixed with BSA aqueous solution 
Fig – 3.3 (b) Bioactive glass ceramic powders – heat treated at 800°C, 850°C & 900°C, mixed with 
BSA solution 
45S5 
glass 
2P 
glass 
4P 
glass 
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The entire  investigation had been carried out in the Department of Biotechnology & Medical 
Engineering, NIT Rourkela. The protein adsorption studies had been carried by corelating the absorption 
capability of bioactive glass powders with Bovine Serum Albumin (BSA) [64].  
Fig – 3.3(c) BSA adsorbed Bioactive glass powders after addition of Bradd Ford Assay 
Fig – 3.3 (d) BSA adsorbed Bioactive glass ceramic powders – heat treated at 800°C, 850°C & 900°C, 
after addition of Bradd Ford Assay 
45S5 
glass 
2P 
glass 
4P 
glass 
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BSA aqueous solution had been prepared at 1200µg/ml concentration. The protein adsorption studies 
had been carried out on triplicate samples of Bioactive glass powders and bioactive glass ceramics, 
which had been heat treated at 800°C, 850°C & 900°C. The samples had been sterilized (section 3.6) 
and added to these BSA aqueous solution at concentration of 10mg/ml [refer Fig – 3.3(a) & 3.3 (b)]. The 
samples had been kept for incubation for period of 24 hours for the adsorption of proteins. Then the 
samples had been centrifuged at 8000 rpm in a REMI Cooling Centrifuge [65]. The supernatant solvent 
had been collected separately and bradford Assay had been added for evaluation of left out protein 
present in the solvent [66]. The optical density measured at 595nm, by using Double beam UV 
Spectrophotometer, Systronicx 2203, had been deducted from the total amount of protein added. This 
gives the amount of protein adsorbed by the bioactive glass and glass ceramic powders.  
3.8 Haemocompatibility analysis of bioactive glass powders 
Blood compatibility or haemocompatibility of the bioactive glass and glass ceramic powders had 
been studied by using a fresh goat blood. The entire  investigation had been carried out in the 
Department of Biotechnology & Medical Engineering, NIT Rourkela.  
Fig – 3.4(a) Haemocompatibility analyses of bioactive glass and glass ceramic powders
– before incubation
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To prevent coagulation, tri-sodium citrate (3.8 g w/v %), Merk India, Reagent Grade, was added to the 
blood. The blood was diluted with normal saline (0.9 % NaCl), Merk India, in the ratio of 8:10 (v/v) as 
the working standard. 10 mg of the samples was taken in a clean test tube and 0.5ml of blood was added 
to it.  
Fig – 3.4(b) Haemocompatibility analyses of bioactive glass powders – after incubation and centrifuge 
The sample volume was made up to 10ml with normal saline (0.9 % NaCl) and kept at 37 °C for 1h. 0.5 
ml of saline and 0.5 ml of 0.1 M HCl were taken as negative and positive controls respectively. After the 
incubation, the solutions were centrifuged at 4000 RPM for 10 min. Absorbance, in terms of optical 
density (O.D) of the supernatant was measured at 545 nm. The samples having percentage hemolysis 
less than 5 % are considered as highly hemocompatible and the samples having percentage hemolysis 
less than 10 % is hemocompatible. The samples which have percentage hemolysis more than 20 % are 
not hemocompatible [67].  
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Fig – 3.4(c) Haemocompatibility analyses of bioactive glass ceramic powders – after incubation and 
centrifuge 
The percentage hemolysis is given by equation, 
          ( )   (
              
             
)      
Where ODTest  – Bioactive glass powders with blood sample 
OD+ve – 0.1M HCl with blood sample 
OD-ve – Saline with blood sample 
Fig – 3.4(c) shows the Haemocompatibility analysis of bioactive glass ceramic powders. Apart from that 
positive control and negative control of the analysis had also been shown in the figure. The positive 
control, the 0.1M HCl solution along with blood sample shows 100% haemolysis and the negative 
control, Saline with blood sample, shows the 0% hemolysis.   
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3.9 Fabrication of porous single layer bioactive glass ceramic scaffolds 
Porous bioactive glass scaffolds had been prepared by using uniaxially pressed and sintering 
method. Naphthalene had been used as a pore former. The glass powders (100, 70 & 50 wt.%)  had been 
mixed with different wt.% of naphthalene (0, 30 & 50 wt.%) and had been binded with 3 wt.% PVA 
solution. The binded mixture had been uniaxially pressed in a hydraulic press, at 260MPa to form 
cylindrical pellets, approximately 12mm diameter. The green samples had been dried at around 90°C for 
6 hours in a hot air owen, for the decomposition of naphthalene. Then the samples had been sintered at 
800, 850 and 900°C for 2 hours.  
3.10 Phase Analysis of bioactive glass and glass ceramic powders 
The amorphous nature and the glass ceramic phases formed beyond the glass transition 
temperature had been investigated by using Philips X-ray Diffractometer with Ni filter Cu-Kα (λ=1.5418 
Å). Along with the milled bioactive glass powders,  glass powders sintered at 700°C, 800°C, 850°C and  
900°C, had been kept for powder diffraction. The diffraction angle(2θ) measured from 15°C to 50°C at a 
scanning rate of 0.05°/min.  
3.11 FTIR Analysis of bioactive glass powders 
The structural analysis of bioactive glass and glass ceramic powders had been studied by using 
FTIR analysis. Bulk glass and glass ceramic powders had undergone transmission of infrared rays by 
using Shimadzu/IR prestige 21, in an ATR mode. The scanning range was around 600 – 1300 cm-1.
3.12 Fabrication of porosity gradient bioactive glass ceramic scaffolds 
As shown in the Fig – 3.6, the two concentric layers of bioactive glass scaffold may mimic the 
anatomy of the bone. The outer dense layer, represents the cortical bone layer and the inner porous layer 
mimics the cancellous bone layer. By uniaxially pressed and sintering, these porosity gradient scaffolds 
had been prepared. Mixing of napthalene, the pore former, into the glass powder had been done as given 
in the table 3.2. 
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Table 3.2 – Preparation of glass powder mixture for Porosity gradient bioactive glass scaffold 
SAMPLE ID 
OUTER LAYER INNER LAYER 
GLASS NAPHTHALENE GLASS NAPHTHALENE 
(030) 100 wt.% 0 wt.% 70wt.% 30 wt.% 
(050) 100 wt.% 0 wt.% 50 wt.% 50 wt.% 
Fig – 3.5 Schematic representation of porosity gradient bioactive glass scaffold 
It should be noted that napthalene, the pore former, had been added only to the mixture prepared for 
cancellous bone layer. Then 3 wt% PVA had been added as a binder to the above mentioned mixtures. 
Then the geometry had been fixed that the total diameter of the scaffold will be 30mm approx. and the 
inner layer diameter will be around 15mm. The fabrication procedure for the porosity gradient bioactive 
glass scaffold had been illustrated in the Fig – 3.6.     
Fig – 3.6 Fabrication of porosity gradient bioactive glass scaffold 
Uniaxial compaction 
Green Porosity gradient 
Structure 
Dense Region (Mimic of Cortical bone layer) 
Porous Region (Mimic of Cancellous bone layer) 
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A hollow glass cylinder, approximately 15mm in diameter, had been kept inside the 30mm cylindrical 
die. It had been placed in such a way that it sits perfectly to the center of the die. The cortical bone layer 
mixture had been filled outside the glass hollow cylinder and cancellous bone layer mixture had been 
filled inside the hollow cylinder. After the powder mixture had been settled down within the cylindrical 
die by gentle tapping, the glass hollow cylinder had been taken out of the die. The entire mixture had 
been uniaxial pressed at around 100MPa. Then the green porosity gradient pellet had been dried at round 
90°C for 6 hours. Later on, the samples had been sintered at 800, 850 and 900°C for 2 hours.  
3.13 Apparent Porosity & Bulk density measurements 
Bulk density and apparent porosity of the sintered scaffolds had been determined by using 
Archimedes principle. In this work, three types of specimens had been characterised.   
1. Scaffolds with Individual / single layer (porous and dense)
2. Entire functionally graded scaffold
3. Outer and inner layer of scaffold
Fig – 3.7 Specimens characterised for Apparent porosity & bulk density 
Dense 
 Porous 
Cortical Cancellous 
(a) Single layers scaffolds (b) FGS (c) Engraved out cortical 
and cancellous layers 
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Fig – 3.7(a) shows the individual layer or single layer scaffolds. Fig – 3.7(b) shows the porosity 
gradient scaffold (FGS) and Fig – 3.7(c) shows the cortical and cancellous bone layers. From the 
functionally graded scaffolds, the cortical and the cancellous bone layers had been cut out with help of a 
diamond tool. After the specimens had been prepared, the dry weight of the sample had been measured 
(Wd). Then they had been immersed in kerosene and kept at vacuum for 1 hour in dessicator. This 
makes the kerosene to get penetrated into the pores. Then soaked weight (Ws) and suspended 
weight(Wa) of the sample had been measured. Finally the apparent porosity and bulk density of the 
samples had been measured by using the formulae as follows:  
                  (
  
     
)                      
                       (
     
     
)      
3.14 Diametral Tensile strength measurements 
In general, diametral tensile strength is a mechanical property used to evaluate the performance 
of brittle materials under tensile stress [68]. The individual layer or single layer scaffolds which had 
been sintered at 800, 850 & 900°C, had undergone diametral tensile strength measurement. The 
Diametric tensile strength had been calculated by using the formula, 
                            
  
   
 (   ) 
Fig – 3.8 Diametral tensile strength of individual / single layer scaffolds 
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3.15 Three point bending moment measurement 
Porous single layer bioactive glass ceramics scaffolds of (60mm x 6mm x 6mm) size had been 
compacted at 100MPa and sintered at 800, 850 & 900°C. With a span of 45mm, the uniaxial loading had 
been given to the samples on 3point bending moment setup as shown in the Fig – 3.9. The flexural 
strength of the samples had been calculated by using the formula,  
                     (
   
    
) 
Fig – 3.9 Three point bending moment of dense bioactive glass ceramic scaffolds 
3.16 Brazilian disc Analysis for FGS 
In rock mechanics, splitting tensile strength is measure due to it gradient microstructures. Since 
the current work is also focussed on Functionally graded material, it is necessary to carry out splitting 
tensile test method. This method and its specimen preparation had been clearly drafted in the ASTM 
standards international, D3967-08 [69]. A lot of specifications has to be followed as per the ASTM 
standards in order to prepare brazilian disc specimens. Thickness to diameter (t/D) ratio should be 
between 0.2 to 0.75. The ends of the specimen had been cut to make it parallel to each other. Brazilian 
disc specimens had been prepared by using a diamond tool and the splitting tensile strength 
measurement had been measured as illustrated in Fig – 3.10.  
45 mm span 
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Fig – 3.10 illustration of splitting tensile strength measurement of FGS 
3.17 Invitro analysis of FGS by using SBF 
The bioactive glass scaffolds prepared had been immersed in Simulated Body Fluid to analyse 
the regeneration capacity. The complete mechanism of bioactive glass scaffolds in SBF had been 
illustrated clearly in the section 1.3.2. Kokubo [70] and many others had designed the SBF concentration 
in such a way that they closly mimic the ion concentrations present in the human blood plasma. Kokubo 
et al [71] had confirmed the formation of apatite layer by soaking the bioglass type scaffolds in SBF. 
The intention of this experiment in this current work is to see how the morphology of apatite layer had 
been differentiated between porous and dense layers of porosity gradient scaffolds. The Table – 3.3 
depicts the close mimic of ionic concentrations of SBF and Human blood plasma designed by Kokubo et 
al [71]. The table – 3.4 gives the raw materials used and amount required for the preparation of 1000ml 
of SBF [72]. In a 2000ml Tarson Beaker, the reagents had been added as per the sequence in 700ml of 
deionised water. The reagents are not added unless the previous reagent had been dissolved in the 
solution. 1M HCl had been added to adjust the ph≈7.4 and the temperature maintained at 33°C. Then the 
solution had been adjusted to 1000ml by adding deoinised water.  
FGS Brazilian disc specimen 
Splitting Tensile 
Strength Measurement 
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Table – 3.3 Illustration of ionic concentration of SBF and Human blood plasma [71]. 
Ion Kukobo et al 
(mM) 
Human Blood 
Plasma (mM) 
Na
+
142.0 142.0 
Cl
-
147.8 103.3 
HCO3
-
34.2 27 
K
+
5.0 5.0 
Mg
2+
1.5 1.5 
Ca
2+
2.5 2.5 
HPO4
2-
1.0 1.0 
SO4
2-
0.5 0.5 
Table – 3.4 Raw materials used for preparation of SBF [72] 
Order Reagent Amount (gpl) 
1 NaCl 6.547 
2 NaHCO3 2.268 
3 KCl 0.373 
4 Na2HPO4.2H2O 0.178 
5 MgCl2.6H2O 0.305 
6 CaCl2.2H2O 0.368 
7 Na2SO4 0.071 
8 (CH2OH)3CNH2 6.057 
Then the 45S5(0,50), functionally graded bioglass scaffold, which had been sintered at 850°C,   
had been kept in a 30ml polysterene container. Almost 20ml of SBF had been poured into the container 
and kept for incubation. The invitro analysis had been carried out for 0,1,7and 14 days. After incubation, 
the  scaffolds had been dried at around 70°C. Furthermore these scaffolds had undergone XRD and 
microstructural analysis to determine the Carbonated-hydroxyapatite formation.    
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3.18 Invitro analysis of FGS with MG-63 cell line 
The purpose of fabricating Functionally graded scaffolds is to obtain a biomimetic approach. The 
outer dense region acts as a protective layer and inner porous region favours better proliferation. The 
level of proliferation will be more in the porous regions than the dense region. In order to determine the 
level of proliferation and cell viability, MG-63 osteoblast cell line had been seeded in to the FGS.  
Fig – 3.11 FGS sample preparation for invitro analysis 
It had been ensured that the sample prepared, by cutting a small portion from the FGS [refer Fig 
3.12(c)], bears both dense region as well as porous region. 45S5 (0,50), 2P(0,50) & 4P(0,50) scaffolds, 
which had been sintered at 850°C, had been used for this investigation. The MG-63 cells had been 
seeded on two batches of FGS specimen, as per the protocol done for bioactive glass powders (refer 
3.6). After incubation, MTT assay had been added to one batch of the specimen, to determine the cell 
viability. With the other batch, the cells had been fixed with 2.5% glutaraldehyde, Sigma Aldrich 25% 
SEM grade, for 2 hours at room temperature [73]. The cell fixed scaffolds had been dehydrated by series 
of concentrations of ethanol and vacuum drying had been done. Then the specimens had been carried for 
microscopic analysis.  
3.11(a) FGS 3.11(b) cutting a small portion 
from FGS 
3.11 (c) FGS sample for 
invitro analysis 
CHAPTER 4 
RESULTS, DISCUSSIONS 
& CONCLUSIONS 
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4. RESULTS & DISCUSSIONS
4.1 SYNTHESIS OF BIOACTIVE GLASS POWDERS 
The glass compositions, 45S5, 2P & 4P (refer table-3.1) had been synthesized by melt quench 
method. The quenched products had been obtained as glass frits which had been grounded and milled to 
make into glass powders. The XRD studies had been done for the milled glass powders which had been 
shown in the fig 4.1. 
Fig 4.1 XRD of as Quenched Melt derived bioactive glass powders 
This XRD spectrum shows that the powders are in the amorphous state and no crystallization 
interference had been taken place during rapid quenching of the melt in water bath. The collected glass 
frits from the water bath had undergone planetary ball milling. On equal milling time, the BET surface 
area of these three bioactive glass powders had been evaluated. The BET Surface Area of about
6.32 m
2
/g, 1.16 m
2
/g & 5.62 m
2
/g had been attained for 45S5, 2P & 4P bioactive glasses respectively.
The corresponding five point BET plots of 45S5, 2P & 4P bioactive glass powders had been given in the 
Fig 4.2 (a), 4.2(b) & 4.2(c) respectively.  
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Fig- 4.2 Five point BET plots of (a) 45S5  (b) 2P  (c) 4P 
4.2 DSC-TG ANALYSIS 
Different bioactive glass compositions mentioned in the compositional diagram (refer Fig – 1.4) had 
been designed by keeping the amount of P2O5 constant at 6 wt.%. Here in this current work, three 
bioactive glass compositions with different amount of P2O5 had been considered. The region S 
mentioned in the same compositional diagram consists of bioactive glass compositions with 36 – 52 wt.
% of silica. Excluding P2O5 in the compositional diagram, the three bioactive glass compositions which 
had been taken in this work, lies in the region of S, which had been categorized as Class A biomaterial. 
Even though these bioactive glass compositions had been formulated within the short region of the 
composition diagram, there are great variations in the thermal behavior. Fig – 4.3(a) illustrates the DSC-
TG curve for 45S5 bioactive glass powder.  
Fig – 4.2(a) 
Fig – 4.2(b) 
Fig – 4.2(c) 
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Fig – 4.3(a) DSC-TG analysis of 45S5 bioactive glass powder 
Since the glass frits had been undergone planetary milling in water medium, there is possibility of 
weight loss. This is because silica has the better affinity towards –OH bonds present in the water 
molecules, which enters the network and forms Si-OH (silanols). Formation of silanols occurs because 
the water molecules either gets entrapped into the pores of the particles or physically adsorbed on the 
surface of the particles. The initial decomposition at around 175°C shows the decomposition of water 
molecules present on the surface of the glass particles. The decomposition at 317°C, 402°C & 645°C 
ensures the stage by stage release of –OH bonds from the silanols formed. A major exothermic peak 
occurs at 690°C due to the phase separation and liquid phase formation. A weak endothermic peak at 
780°C represents the onset of crystallization or glass ceramic phase formation. The endothermic peak 
observed at 870°C indicates the major crystallization.  
Fig – 4.3(b) illustrates the DSC-TG curve of 2P bioactive glass powder. Similar to 45S5 bioactive glass 
powders, 2P bioactive glass also registers some weight loss due to the release of –OH bonds from the 
silanols, till 609°C. 
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Fig – 4.3(b) DSC-TG analysis of 2P bioactive glass powder 
The major exothermic reaction got initiated at 690°C which further proceeds with an endothermic peak 
at 770°C. As the exothermic reaction is predominantly interrupted by endothermic peak, this bioactive 
glass composition is pruned to crystallization beyond 800°C.  
Fig – 4.3(c) shows the DSC-TG curve of 4P bioactive glass powder. The –OH bonds from the silanols 
formed from the 4P bioactive glass powders had been released at different amount on 93°C, 205°C, 
288°C, 443°C, 667°C & 727°C.  Beyond the major exothermic peak at 685°C, there initiates a slight 
endothermic peak at 725°C, which initiates the onset of crystallization of 4P bioactive glass. Beyond 
that there is consecutive fall in heat flow and emerges back with endothermic peaks at 785°C, 840°C, 
875°C and a weak endothermic peak at 900°C. This shows the simultaneous reactions of phase 
separation and crystallizations at high temperatures. But the glass ceramic phase formation of 4P 
bioactive glass starts from the temperature of 725°C.  
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Fig – 4.3(c) shows the DSC-TG curve of 4P bioactive glass powder 
When the thermal behavior of these three bioactive glass powders had been compared, it had been 
observed that the glass composition with least amount of P2O5 had utilized higher amount of heat flow 
to initiate the major exothermic peak. When the amount of P2O5 increases, the proportion of Q3 species 
had been increased, which further results with pronounced crystallization [79]. Thus apart from the other 
modifiers Na2O and CaO, P2O5 plays a major role on the thermal behavior on the glass system. 
4.3 DILATOMETRIC ANALYSIS 
In order to understand the sintering behavior of bioactive glass scaffolds, it is necessary to undergo 
dilatometric analysis. The rectangular compacts had been fired in the dilatometric furnace under argon 
atmosphere.   
The Fig – 4.4(a) illustrates the sintering behavior of 45S5 bioactive glass compacts. From 89°C to 
181°C, there is a slight decrease in volume, which is due to the evaporation of water molecules 
associated with the binder.  
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Fig – 4.4(a) – Dilatometric analysis of 45S5 bioactive glass green compacts 
Till 607°C, there is no substantial linear shrinkage observed, which less than 0.6%. By a drastic fall at 
607°C, sintering got initiated and proceeds till 745°C. This drastic fall indicates the liquid phase 
formation and phase separation. At 800°C, 850°C and 900°C, linear shrinkage of about 15.27%, 15.21% 
and 15.14% had been observed respectively.  
Fig – 4.4(b) Fractured surfaces of 45S5 glass ceramics sintered at 800°C (without pore former) 
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Fig – 4.4(c) Fractured surfaces of 45S5 glass ceramics sintered at 850°C (without pore former) 
Fig – 4.4(d) Fractured surfaces of 45S5 glass ceramics sintered at 900°C (without pore former) 
Fig – 4.4(b), Fig – 4.3(c) & Fig – 4.3(d) shows the microstructures of 45S5 glass ceramics sintered at 
800°C, 850°C & 900°C respectively. The microstructures given in the Fig- Fig – 4.4(b), Fig – 4.3(c) & 
Fig – 4.3(d) shows that the efficient densification is not carried out. The simultaneous crystallization and 
phase separates retards the densification mechanism.  
 .  
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Fig – 4.4 (e) Dilatometric analysis of 2P bioactive glass green compacts 
Fig–4.3(e) illustrates the sintering behavior of 2P bioactive glass compact. This composition undergoes 
two stages of sintering. During the first stage of sintering, the compact tends to contract from 91°C to 
273°C, at a linear shrinkage of about 3.62%. Till 542°C, there is no significant increase in linear 
shrinkage. Beyond that temperature, the second stage of sintering took place, with a drastic fall till 
705°C. At that temperature, the linear shrinkage was around 13.47%. Then reduction of volume got 
saturated when it reaches 800°C. For 2P bioactive glass compact, the linear shrinkage of about 15.44%, 
15.76% & 15.84% had been recorded at the temperatures 800°C, 850°C & 900°C respectively.    
Fig – 4.4(f) Fractured surfaces of 2P glass ceramics sintered at 800°C (without pore former) 
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Fig – 4.4(g) Fractured surfaces of 2P glass ceramics sintered at 850°C (without pore former) 
Fig – 4.4(h) Fractured surfaces of 2P glass ceramics sintered at 900°C (without pore former) 
Fig – 4.4(f), Fig – 4.4(g) & Fig – 4.4(h) shows the microstructures of 2P glass ceramics sintered at 
800°C, 850°C & 900°C. The microstructures clearly shows that the densification had been carried out 
efficiently within minimum amount of pores present.  
Fig – 4.3(i) illustrates the sintering behavior of 4P bioactive glass compact. From 105°C to 217°C, there 
is a slight contraction due to the evaporation of water molecules and moisture present in the sample. At 
615°C, the linear shrinkage was about 10.13%, which further leads to a drastic fall in volume till 800°C. 
At 800°C, the linear shrinkage was around 13.56%. There is a slight fall in volume again when the 
temperature proceeds to 850°C, where the linear shrinkage had been recorded as 14.38%.  
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Fig – 4.4 (i) Dilatometric analysis of 4P bioactive glass green compacts 
A little amount of contraction took place when the temperature proceeds towards 900°C, with a linear 
shrinkage of about 14.62%. The saturation of volume shrinkage had been reduced when the temperature 
is beyond 850°C. The Fig – 4.4 (j), 4.4 (k) & 4.4 (l) shows the microstructures of 4P bioactive glass 
ceramics at the fracture surfaces.  
 Fig – 4.4(j) Fractured surfaces of 4P glass ceramics sintered at 800°C (without pore former) 
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Fig – 4.4(k) Fractured surfaces of 4P glass ceramics sintered at 850°C (without pore former) 
Fig – 4.4(l) Fractured surfaces of 4P glass ceramics sintered at 900°C (without pore former) 
From the Fig – 4.4(j), Fig – 4.4(k) & Fig – 4.4(l), it shows that more amount inter particle voids had 
been observed even after sintering at 900°C. When compared to the other two glass ceramics, 4P glass 
ceramics shows higher amount of porosity on the fracture surface. On comparing the sintering behavior 
of these three bioactive glass composition, it had been observed that the saturation of linear shrinkage 
had been took place within the temperatures 800°C and 900°C. As discussed in the previous section, 
there will be corresponding increase in Q3 species when there is an increase in P2O5. Due to this reason, 
during the course of sintering, the average degree of polymerization of Si network had increased.  
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Thus the actual densification mechanism commences at higher temperature, if the amount of P2O5 
increases. Since the linear shrinkage of the bioactive glass compacts got saturated within the temperature 
range of 800°C to 900°C, the sintering temperatures of bioactive glass scaffolds had been fixed as 
800°C, 850°C & 900°C. 
4.4 PHASE ANALYSIS OF BIOACTIVE GLASS CERAMIC POWDERS 
For the fabrication of bioactive glass ceramic scaffolds, uniaxial pressing and sintering method had been 
utilized. From the previous section, it had been decided to sinter the bioactive glass ceramic scaffolds at 
800°C, 850°C & 900°C. From the literatures it had been well understood that sintering of bioactive glass 
green scaffolds leads to crystallization and formation of glass ceramic phases. Therefore it is necessary 
to identify the glass ceramic phases formed on post sintering.     
* Na4Ca4Si6O18
ϕ Na
2
Ca
3
Si
6
O
16
• Na2Ca4 (PO4)2SiO4
Fig – 4.5 (a) Phase Analysis of 45S5 Bioactive glass ceramics 
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Fig – 4.5(a) shows the phases formed by the sintered 45S5 bioactive glass ceramic. At 700°C, the 45S5 
retains its amorphous state and crystallization had been observed from 800°C. This shows that glass 
ceramic phase formation had occurred within the temperatures 700°C and 800°C. Sodium Calcium 
Silicate – Na4Ca4Si6O18 is the major phase formed at 800°C, which had been matched by its reference 
pattern 75-1686. Na2Ca3Si6O16 (77-0386) is the secondary phase formed and Na2Ca4 (PO4)2SiO4
(33-1229) appears as a minor phase. Similar phases had been formed when the 45S5 glass fired at 850°C 
and 900°C. No major phase transformations occurred with the 45S5 glass ceramics when the sintering 
temperature proceeds towards 850°C and 900°C.  
* Na4Ca4Si6O18
ϕ Na
2
Ca
3
Si
6
O
16
• Na2Ca4 (PO4)2SiO4
Fig – 4.5 (b) Phase Analysis of 2P Bioactive glass ceramics 
Fig – 4.5(b) illustrates the phase formation of 2P bioactive glass ceramic at the temperatures 700°C, 
800°C, 850°C and 900°C. Similar to 45S5 bioactive glass fired at 700°C, 2P bioactive glass also retains 
its amorphous state at 700°C. The major crystallization peak had been observed from Na4Ca4Si6O18.  
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The secondary phase Na4Ca4Si6O18 and Na2Ca4 (PO4)2SiO4 had been identified as secondary phase and 
minor phase of the 2P glass ceramic system. The initiation of phase separation of Na2Ca4 (PO4)2SiO4 had 
been observed, when the sintering temperature increases from 800°C to 850°C, due to less amount of 
P2O5 present in the glass composition. Excluding that no major phase transformation had been observed.  
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Fig – 4.5 (c) Phase Analysis of 4P Bioactive glass ceramic 
Fig – 4.5(c) shows the glass ceramic phase formation on 4P bioactive glass ceramic. Even this 
composition retains its amorphous nature when fired at 700°C. Na4Ca4Si6O18 – 75-1686 is the major 
phase formed on 4P bioactive glass and Na2Ca3Si6O16 (77-0386) is the secondary phase.
Na2Ca4 (PO4)2SiO4 had been identified as minor phase of the 4P glass ceramic system. In the 
temperature range of 800°C - 900°C, active crystallization had been carried out. But major 
transformation was not observed in all the glass compositions.  
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4.5 FTIR ANALYSIS 
Fig- 4.6(a) FTIR spectra of 45S5 bioactive glass and glass ceramics 
Fig – 4.6 (a) shows the FTIR spectra of 45S5 bioactive glass and glass ceramics sintered at 800°C, 
850°C & 900°C. An asymmetric Si-O-Si stretching at 960 cm
-1 
and Si-O-Si bending at 760 cm
-1
 had
been attributed to the 45S5 glass. On post sintering, due to crystallization, the Si-O-Si bond deflects for 
an asymmetric stretch of Si-O-NBO in Q2 and Q1 occurs at 860 cm
-1
, which indicates the presence of
bioactive glass ceramic phase formation. Further, the band at 950 cm
-1
 corresponds to the Si-O-Si
stretching vibration mode of glass ceramics. A band at 640 cm
-
1 indicates P-O bending vibration and the
band at 700 cm
-1
 corresponds to P-O-P unit stretching which indicates the presence of crystalline
phosphate. [74-79]  
Fig – 4.6(b) shows the FTIR spectra of 2P bioactive glass and glass ceramics sintered at 800°C, 850°C 
& 900°C. 
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Fig- 4.6(b) FTIR spectra of 2P bioactive glass and glass ceramics 
Due to less amount of P2O5 present in the 2P bioactive glass composition, P-O bending vibration 
occurred as a weak band at 640 cm
-1
. A narrow Si-O-Si asymmetric stretching had been occurred at
990 cm
-1
. On crystallization, Si-O-Si band deflects and Si-O-NBO stretches at 860 cm
-1
, whereas 2P
glass stretches at 870 cm
-1
.  Due to this strong asymmetric stretching, overlapping of PO4 occurs. This
results in P-O-P vibrations at 680 cm-1 and 690 cm-1 for 2P bioactive glass and glass ceramics 
respectively. [74-79] 
Fig – 4.6(b) shows the FTIR spectra of 2P bioactive glass and glass ceramics sintered at 800°C, 850°C 
& 900°C. 
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Fig- 4.6(c) FTIR spectra of 4P bioactive glass and glass ceramics 
The band at 975cm
-1
 and 985cm
-1
 corresponds to the asymmetric Si-O-Si stretching of 4P bioactive
glass and glass ceramics. The band at 690 cm
-1
 corresponds to the P-O-P unit stretching of Q3 in Q2 and
Q1. On crystallization, the Si-O-Si stretching vibration mode at 1100 cm
-1
 had been observed. On post
sintering, due to crystallization, the Si-O-Si bond deflects for an asymmetric stretch of Si-O-NBO in Q2 
and Q1 occurs at 850 cm
-1
. [74-79]
On a comparison of 45S5, 4P and 2P bioactive glass compositions, the structural features of 45S5 and 
4P are similar. But due to less P2O5 in 2P glass composition, a strong Si-O-Si stretching had been 
incurred by the glass system.  
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4.6 CELL VIABILITY OF BIOACTIVE GLASS AND GLASS CERAMICS 
The MG-63 cell line had been seeded to the bioactive glass and glass ceramics as per the protocol 
prescribed in the section 3.6. On sintering, since the bioactive glasses transforms into glass ceramics, it 
is necessary to evaluate the cell viability on glass ceramics. In this experiment, including the bioactive 
glasses, 45S5, 2P & 4P, its corresponding glass ceramics, which had been fired at 800°C, 850°C & 
900°C, had also tested. Fig – 4.7 (a) shows the phase contrast microscopic images of MG-cell seeded 
bioactive glasses.  
Fig-4.7 (a) Phase contrast microscopic image of cell seeded bioactive glass and glass ceramics after 
1 day incubation 
CONTROL 
45S5 GLASS 45S5 800 45S5 850 45S5 900 
2P GLASS 2P 800 2P 850 2P 900 
4P 900 
4P 850 4P 800 4P GLASS 
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Fig-4.7 (b) MTT Cell viability of Bioactive glasses and glass ceramics 
After one day incubation, by using MTT Assay, the cell viability index had been evaluated for bioactive 
glass and glass ceramics, which had been illustrated in the Fig – 4.7(b). Since all the samples have the 
cell viability index of more than 0.7, it had been ensured that all the samples are biocompatible. Except 
4P 850, all the samples are having cell viability index more than the control. Cell viability index of 2P 
850 is less when compared with 2P 800 & 2P 900. Similarly cell viability index of 4P 850 is less when 
compared with 4P 800 & 4P 900. This feature is not seen with 45S5 glass and its glass ceramics. Except 
4P 850, the cell viability of all the glasses are less than the cell viability of its corresponding glass 
ceramic. On an overall comparative study it had been concluded that 2P based bioactive glass ceramics 
induces more proliferation than 45S5 and 4P based glass and glass ceramics. 2P bioactive glass 
composition has higher silica content (49.5wt. %) than the other two glass compositions. Since Si
4+
 ions
are responsible for osteogenesis and angiogenesis (refer table 1.2), it had been concluded that 2P based 
bioactive glass ceramics are highly biocompatible than the 45S5 and 4P based glass and glass ceramics.    
69 
4.7 HAEMOCOMPATIBILITY OF BIOACTIVE GLASS AND GLASS CERAMICS 
Hemolysis study can be interpreted for the evaluation of blood compatibility of the bioactive glass and 
glass ceramics. Fig – 4.8 shows the % hemolysis of bioactive glass and glass ceramics.  
Fig – 4.8 Hemolysis Study of bioactive glass and glass ceramics 
On all the samples, % Hemolysis is less than 5% and greater than the Negative control. This ensures that 
all the samples are highly hemocompatible. The highest % Hemolysis had been observed in 45S5 800 & 
the least % Hemolysis had been recorded by 4P 800. In the case of 2P based glass and glass ceramics, 
the % hemolysis is less than 45S5 based glass and glass ceramics. But the amount of hemolysis in 2P 
based glass and glass ceramics had occurred more than 4P based glass and glass ceramics.  
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4.8 PROTEIN ABSORPTION STUDIES 
Bovine Serum Albumin (BSA) had been used as a reference protein for the evaluation of protein 
absorption of bioactive glasses and glass ceramics. Fig – 4.9 shows the protein absorption profiles of 
bioactive glasses and glass ceramics.  
Fig – 4.9 Protein Adsorption studies of Bioactive glass and glass ceramics 
All protein adsorption profiles had been recorded within the range of 45-60 mg/ mg of the sample. All 
the glass ceramic samples adsorbs more than the corresponding glass samples. Among the all other 
samples, 45S5 850 adsorbs 53.67 mg of BSA per mg of itself. The least adsorption had been registered 
by 45S5 bioactive glass; almost 48.04 mg of BSA/mg. 2P based glass ceramics shown a moderate 
adsorption capability.    
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4.9 APPARENT POROSITY & BULK DENSITY OF SINGLE LAYER SCAFFOLDS 
By using naphthalene as a pore former (0wt.%, 30wt.% & 50wt.%), fabrication of single layer bioactive 
glass ceramic scaffolds had been done by uniaxial pressing and sintering method. As mentioned earlier, 
the single layer scaffolds had been sintered at 800°C, 850°C and 900°C. Fig – 4.10.1 (a), Fig – 4.10.1(b) 
& Fig – 4.10.1(c) illustrates the apparent porosity & bulk density of Single layer - 45S5 porous bioactive 
glass ceramic scaffolds with 0 wt.%, 30wt.% and 50wt.% of naphthalene respectively.   
Fig – 4.10.1(a) Apparent porosity and bulk density of 45S5 single layer scaffold with 0 wt. % 
naphthalene 
Without pore former (0 wt.% naphthalene), 45S5 single layer scaffolds had been fabricated. The 
maximum bulk density had been attained at 800°C itself. There is no significant increase in bulk density 
had been noticed when the temperature rises from 800°C to 900°C. The Apparent porosity had been 
saturated within 31-33 vol.% and the bulk density had been attained within the range of 1.83g/cc-
1.87g/cc.  
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Fig – 4.10.1(b) Apparent porosity and bulk density of 45S5 single layer scaffold with 30 wt. % 
naphthalene 
Fig – 4.10.1(c) Apparent porosity and bulk density of 45S5 single layer scaffold with 50 wt. % 
naphthalene 
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Even in the case of 45S5 single layer scaffolds with 30 wt.% and 50 wt.% of naphthalene, the maximum 
strength had been attained at 800°C itself. There is no substantial increase in bulk density when the 
sintering temperature from 800°C to 850°C and 900°C. Table 4.1 illustrates the apparent porosity and 
bulk density attained by Porous 45S5 single layer scaffolds sintered at 800°C to 850°C and 900°C. 
Table – 4.1 Apparent Porosity (A.P) and Bulk density (B.D) of Porous 45S5 Single layer scaffolds 
Sintering 
Temperature 
(°C) 
45S5     
(0 wt.% Naphthalene) 
45S5     
(30 wt.% Naphthalene) 
45S5     
(50 wt.% Naphthalene) 
A.P 
(vol.%) 
B.D 
(g/cc) 
A.P 
(vol.%) 
B.D 
(g/cc) 
A.P 
(vol.%) 
B.D 
(g/cc) 
800 33.23 1.83 56.94 1.17 68.67 0.853 
850 31.78 1.85 56.28 1.19 68.65 0.858 
900 31.21 1.86 56.01 1.21 68.58 0.862 
Fig – 4.10.2 (a), Fig – 4.10.2 (b) & Fig – 4.10.2 (c) shows the Apparent Porosity and bulk density of 2P 
based bioactive glass ceramics with 0wt.%, 30wt.% & 50wt.% Naphthalene respectively.  
Fig – 4.10.2(a) Apparent porosity and bulk density of 2P single layer scaffold with 0 wt. % 
naphthalene 
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2P single layer scaffolds, when sintered without pore former, minimum apparent porosity of less 0.5 
vol.% had been attained. It had recorded a bulk density of about 2.6 g/cc, which is considered to be the 
highest dense among the other scaffolds tested. A drastic increase in bulk density had been noticed when 
the sintering temperature increases from 800°C to 850°C. When the sintering temperature increases to 
900°C, the rate of increase in density had been saturated.  
Fig – 4.10.2(b) Apparent porosity and bulk density of 2P single layer scaffold with 30 wt. % 
naphthalene 
Similar behavior had been observed with 2P Single layer scaffolds with 30wt.% naphthalene. There is a 
commendable increase in bulk density when the sintering temperature increases from 800°C to 850°C. 
Then the value of bulk density had been saturated when the scaffolds had been fired at 900°C. The 
attained apparent porosity is very much close to the volume of naphthalene incorporated into the 
scaffolds. Even the same sintering behavior had been observed with 2P single layer scaffolds with 
50wt.% naphthalene.    
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Fig – 4.10.2(c) Apparent porosity and bulk density of 2P single layer scaffold with 50 wt. % 
naphthalene 
The values of Apparent Porosity and bulk density attained by 2P single layer scaffolds with different 
amount of naphthalene addition had been tabulated in the Table – 4.2.  
Table – 4.2 Apparent Porosity (A.P) and Bulk density (B.D) of Porous 2P Single layer scaffolds 
Sintering 
Temperature 
(°C) 
2P     
(0 wt.% Naphthalene) 
2P     
(30 wt.% Naphthalene) 
2P     
(50 wt.% Naphthalene) 
A.P 
(vol.%) 
B.D 
(g/cc) 
A.P 
(vol.%) 
B.D 
(g/cc) 
A.P 
(vol.%) 
B.D 
(g/cc) 
800 0.34 2.349 32.96 1.78 49.33 1.37 
850 0.23 2.607 32.25 1.84 46.98 1.45 
900 0.06 2.609 31.57 1.85 46.20 1.46 
Fig – 4.10.3 (a), Fig – 4.10.3 (b) & Fig – 4.10.3 (c) shows the Apparent Porosity and bulk density of 4P 
glass ceramics with 0wt.%, 30wt.% & 50wt.% Naphthalene addition respectively. 
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Fig – 4.10.3(a) Apparent porosity and bulk density of 4P single layer scaffold with 0 wt. % 
naphthalene 
Fig – 4.10.3(b) Apparent porosity and bulk density of 4P single layer scaffold with 30 wt. % 
naphthalene 
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Fig – 4.10.3(c) Apparent porosity and bulk density of 4P single layer scaffold with 50 wt. % 
naphthalene 
4P based porous single layer scaffolds had been considered as highly porous scaffolds among the other 
single layer scaffolds. Apparent Porosity of 39-42vol.%, 56-58 vol.% & 69-70 vol.% had been recorded 
for 2P single layer scaffolds with 0wt.%, 30wt.% & 50wt.% of naphthalene respectively. 4P single layer 
scaffold with 0 wt.% naphthalene attained its maximum density at 800°C. A little marginal increase of 
bulk density had been observed when the sintering temperature increases to 850°C. When the sintering 
temperature proceeds to 900°C, it tends to increase its bulk density, but not to a greater extent. In the 
case of 4P single layer scaffolds with 30wt.% naphthalene, there was a drastic increase in bulk density 
when the sintering temperature increases from 800°C to 850°C. Then the rate of increase in bulk density 
had been suppressed when the sintering temperature proceeds towards 900°C. A gradual increase in bulk 
density had been observed with 4P (50wt.% naphthalene) single layer scaffolds, when the sintering 
temperature proceeds from 800°C to 850°C and goes on to 900°C. The tabulated results of apparent 
porosity and bulk density for 4P single layer scaffolds had been drafted in the table 4.3.  
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   Table – 4.3 Apparent Porosity (A.P) and Bulk density (B.D) of Porous 4P Single layer scaffolds 
Sintering 
Temperature 
(°C) 
4P     
(0 wt.% Naphthalene) 
4P     
(30 wt.% Naphthalene) 
4P     
(50 wt.% Naphthalene) 
A.P 
(vol.%) 
B.D 
(g/cc) 
A.P 
(vol.%) 
B.D 
(g/cc) 
A.P 
(vol.%) 
B.D 
(g/cc) 
800 42.01 1.58 57.97 1.15 69.90 0.82 
850 41.78 1.59 56.08 1.18 69.53 0.83 
900 39.98 1.62 56.07 1.19 69.19 0.84 
Each glass composition behaves differently, when compacted and sintered at 800°C, 850°C & 900°C, 
due to emergence of degree of polymerization at different temperature ranges, as discussed in the 
dilatometric analysis via section 4.3.  The average degree of polymerization eventually occurs during the 
course of liquid phase formation and phase separation. This had been characteristically illustrated by a 
plateau of drastic increase in linear shrinkage on the dilatometric profiles [Fig – 4.4 (a), Fig – 4.4 (e) & 
Fig – 4.4 (i)]. Due to less amount of P2O5 in the 2P bioactive glass composition, as mentioned earlier 
(section 4.2), the glass compacts attains the degree of polymerization well before 650°C. This 
polymerization, at this temperature range triggers the liquid phase formation, which actually promoted 
viscous flow sintering. As a result, the densification mechanism was rigorous and 2P bioactive glass 
scaffold (without pore former) attained maximum bulk density of 2.34 g/cc (0.34 vol. % of apparent 
porosity), at sintering temperature of 800°C. Similar strategy had been followed by 2P based porous 
scaffolds (30 & 50 wt. % of Naphthalene), when sintered at 800°C. The attained apparent porosity on 2P 
based porous scaffolds, when sintered at 800°C, where approximately equal to the amount of 
Naphthalene (pore former) incorporated. Beyond this temperature, i.e when 2P based scaffolds sintered 
at 850°C and 900°C, incremented bulk density had been achieved, but the performance of viscous flow 
sintering had been more rigorous. Thus for 2P based scaffolds, 800°C had been considered as an 
optimum sintering temperature.  
In this section, as per the tabulated results of bulk density, the next better dense bodies had been 
achieved by 45S5 bioglass composition. With reference of the dilatometric profile of 45S5 bioglass 
composition [Fig – 4.4 (a)], it can be concluded that the degree of polymerization originates within the 
temperature - 650°C to 700°C. Hence the prominent densification mechanism happens during this 
period.  
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Furthermore, apart from liquid phase formation and phase separation, simultaneous crystallization took 
place, which lags the densification mechanism, when compared with 2P based scaffolds. Thus the 
amount of pore former incorporated into the 45S5 based scaffolds approximately equalizes with the 
attained apparent porosity, when the sintering temperature is beyond 800°C (Table 4.1). With this it can 
be concluded that the optimum level of sintering had been attained by 45S5 based scaffolds, when the 
sintering temperature is 850°C.  
Among these three bioglass composition, 4P based scaffolds were considered as the weakest one. As per 
the dilatometric profile of 4P bioglass composition [Fig – 4.4 (i)], the degree of polymerization emerges 
beyond 690°C. This is a delayed happening when compared with 45S5 and 2P bioglass composition. 
Additional to that, as per the dilatometric profile of 4P bioglass composition, the linear shrinkage had 
not been saturated even at 900°C. As a result sintering mechanism had been considerably postponed to 
higher sintering temperature. 2P based scaffolds achieves better sintering at 800°C itself due to less 
amount of P2O5. But 45S5 bioglass composition, even though possessed higher amount of P2O5 than 4P 
bioglass composition, the optimum sintering temperature was 850°C only. This is due to the excess 
amount of SiO2 present in 4P bioglass composition than 45S5 bioglass composition. Higher amount of 
SiO2 delays the polymerization and also drags the liquid phase formation. Hence sintering mechanism 
had been retarded on 4P based scaffolds and also by the matter of fact, apparent porosity is also higher 
than the other scaffolds. Thus 4P based scaffolds demands for higher temperature than 900°C, to attain 
an optimum level of sintering. 
In this section, the optimum sintering temperature had been decided based on two preliminary 
requirements. As per the application point of view, scaffolds requires better dense bodies, at the same, 
they should retain some appreciable amount of porosity on it, on post sintering, to favor osteogenesis. 
And hence the above conclusions had been illustrated.     
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4.10 DIAMETRAL TENSILE STRENGTH OF POROUS SINGLE LAYER SCAFFOLDS 
As the main objective of this work is majorly focused on Porosity gradient bioactive glass ceramic 
scaffolds, evaluation of tensile strength plays a pivotal role. Fig – 4.10.1, Fig – 4.10.2 & Fig – 4.10.3 
illustrates the Diametral Tensile strength (DTS) of Porous 45S5, 2P & 4P single layer scaffolds 
respectively.  
Fig – 4.11.1 Diametral Tensile strength of Porous 45S5 Single Layer scaffolds 
Diametral Tensile Strength of 45S5 (0P) had been recorded as 6.78MPa, 8.57MPa & 8.81MPa on 
sintering temperatures 800°C, 850°C & 900°C. A drastic increase in DTS from 800°C to 850°C had 
been observed and the rate of increase is reduced when the sintering temperature proceed to 900°C. This 
feature had not shown with 45S5 (30P) & 45S5 (50P). 
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Fig – 4.11.2 Diametral Tensile strength of Porous 2P Single Layer scaffolds 
Sudden increase in DTS had been observed with the scaffold 2P (0P) when the sintering temperature 
rises from 850°C to 900°C. On rest of the 2P based porous single layer scaffolds, a normal increase in 
DTS had been observed on increase in sintering temperature. Since 2P based porous scaffolds are the 
highly dense when compared with 45S5 and 4P based porous single layer scaffolds, they results with 
better diametral tensile strength than the other single layer scaffolds.  
The diametral tensile strength of porous 4P single layer scaffolds had been illustrated in the Fig – 4.11.3. 
In the case of 4P based porous single layer scaffolds, the rate of increase in DTS is comparatively high 
for 4P (0P) & 4P (30P) than 4P (50P). A large increase in DTS had been seen with the samples 4P (0P) 
at 800°C to 850°C and 4P (30P) at 850°C to 900°C. On rest of the 4P based porous single layer 
scaffolds, a linear increase in DTS had been recorded. 
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Fig – 4.11.3 Diametral Tensile strength of Porous 4P Single Layer scaffolds 
The tabulated results for the Diametral Tensile Strength of Porous Single layer scaffolds had been 
drafted in the table 4.4.  
Table – 4.4 Diametral Tensile strength of Single Layer Bioactive glass ceramic scaffolds 
Sintering 
Temperature 
(in °C) 
Diametral Tensile Strength (MPa) 
45S5 2P 4P 
0P 30P 50P 0P 30P 50P 0P 30P 50P 
800 6.78 3.13 1.07 10.94 9.26 6.46 5.09 4.48 0.98 
850 8.57 3.48 1.09 11.30 9.79 7.00 5.80 4.64 1.17 
900 8.81 3.75 1.37 13.84 9.87 7.27 5.93 5.48 1.27 
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4.11 FLEXURAL STRENGTH OF POROUS SINGLE LAYER SCAFFOLDS 
The three point bending moment test on Porous Single layer scaffolds indulges in the evaluation of 
flexural strength of the scaffolds. Fig – 4.12.1, Fig – 4.12.2 & Fig – 4.12.3 shows the flexural strength of 
porous 45S5, 2P & 4P single layer scaffolds respectively for the corresponding sintering temperatures.  
Fig – 4.12.1 Flexural strength of Porous 45S5 Single Layer scaffolds 
Porous 45S5 single layer scaffolds shows a steady state increase in flexural strength, when the sintering 
temperature increases from 800°C to 900°C. As the porosity increases, the corresponding amount of 
strength had been reduced.  
A drastic increase in Flexural strength had been recorded when the sintering temperature rises from 
800°C to 850°C for 2P (0P) sample. When the temperature proceeds to 900°C a normal increase in 
Flexural strength had been observed on 2P (0P) sample. Rest of the 2P porous based single layer 
scaffolds registered a linear increase in flexural strength as the sintering temperature increases.  
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Fig – 4.12.2 Flexural strength of Porous 2P Single Layer scaffolds 
Fig – 4.12.3 Flexural strength of Porous 4P Single Layer scaffolds 
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In the case of 4P based porous single layer scaffolds, rate of increase in flexural strength was high, when 
the temperature increases from 800°C to 850°C. When the temperature increases to 900°C, the flexural 
strength increases more than the samples of previous sintering temperatures. These observations had 
been observed with the samples 4P (0P) & 4P (30P). 4P (50P) registered a linear increase in flexural 
strength when the temperature increases from 800°C to 900°C. The flexural strength values for the 
corresponding sintering temperatures had been tabulated in the table – 4.5. 
 Table – 4.5 Flexural strength of Single Layer Bioactive glass ceramic scaffolds 
Sintering 
Temperature 
(in °C) 
Flexural strength (MPa) 
45S5 2P 4P 
0P 30P 50P 0P 30P 50P 0P 30P 50P 
800 7.63 3.52 1.19 24.50 20.73 14.47 4.37 3.84 0.84 
850 9.42 3.83 1.21 36.40 26.75 19.13 6.64 5.31 1.34 
900 11.98 5.10 1.86 37.52 31.55 23.24 10.12 9.36 2.18 
On an overall comparison of the flexural strength of porous single layer scaffolds, 2P based scaffolds 
attains better flexural strength than the other single layer scaffolds. As mentioned in the section 4.9, this 
is again due to less amount of P2O5 present in 2P bioglass composition and viscous flow sintering. 
4.12 APPARENT POROSITY & BULK DENSITY OF FGS 
With 45S5, 2P & 4P glass composition and by uniaxial pressing and sintering method, porosity gradient 
or functionally graded bioactive glass ceramic scaffolds had been fabricated as per the protocol drafted 
in the section __. The fabricated green porosity gradient bioactive glass scaffolds had been sintered at 
800°C, 850°C & 900°C. Fig – 4.13.1 shows the polished surface of porosity gradient bioactive glass 
ceramic scaffold.  
Fig – 4.13.1 Polished surface of porosity 
gradient scaffolds 
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 Two types of porosity gradient bioactive glass ceramic scaffolds had been prepared which had been 
represented by (0,30) and (0,50). (0,30) represents 0wt.% naphthalene added for outer layer and 30wt.% 
naphthalene added for inner layer. Similarly (0,50) represents 0wt.% naphthalene added for outer layer 
and 50wt.% naphthalene added for inner layer.  
The apparent porosity & bulk density of the entire porosity gradient scaffold had been evaluated.
Fig – 4.13.2, Fig – 4.13.3, Fig – 4.13.4, Fig – 4.13.5, Fig – 4.13.6 & Fig – 4.13.7 shows the Apparent 
porosity & Bulk density of 45S5(0,30), 45S5(0,50), 2P(0,30), 2P(0,50), 4P(0,30) & 4P(0,30) bioactive 
glass ceramic scaffolds respectively.  
Fig – 4.13.2 Apparent Porosity & Bulk density of FGS-45S5 (0,30) 
The overall apparent porosity of the entire FGS scaffold, FGS 45S5 (030) achieved from 42 vol.% to 38 
vol.% for the sintering temperatures 800°C, 850°C & 900°C. The bulk density had been achieved within 
the range of 1.55 g/cc to 1.66g/cc. 
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Fig – 4.13.3 Apparent Porosity & Bulk density of FGS-45S5 (0,50) 
Fig – 4.13.4 Apparent Porosity & Bulk density of FGS-2P (0,30) 
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In the case of FGS – 45S5(0,50), a gradual reduction of apparent porosity had been achieved, from 48 
vol.% to 44 vol.% on increasing sintering temperatures. And 1.37 g/cc to 1.47 g/cc of bulk density had 
been recorded.   
Fig – 4.13.5 Apparent Porosity & Bulk density of FGS-2P (0,50) 
FGS 2P (0,30) observes a sudden drop in apparent porosity when the sintering temperature rises from 
850°C to 900°C. Approx. 18 vol.% to 15 vol.% of apparent porosity and 2.10 g/cc to 2.25 g/cc of bulk 
density had been recorded on different sintering temperatures.  
For FGS 2P (050), major amount of pore reduction had been attained at the sintering temperature of 
800°C itself. When the sintering temperature increases from 850°C to 900°C, less amount of apparent 
porosity had been dropped.  
FGS 4P (030) possess a gradual reduction of apparent porosity, which had been attained when the 
sintering temperature increases from 800°C to 850°C and then to 900°C.  
The rate of reduction of apparent porosity had been totally reduced when the sintering temperature 
increases from 850°C to 900°C in FGS 4P (050) 
. 
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Fig – 4.13.6 Apparent Porosity & Bulk density of FGS-4P (0,30) 
Fig – 4.13.7 Apparent Porosity & Bulk density of FGS-4P (0,50) 
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Table – 4.6 Apparent Porosity (A.P) & Bulk density (B.D) of Entire FGS 
Sintering 
Temp. 
(°C) 
45S5 2P 4P 
(0,30) (0,50) (0,30) (0,50) (0,30) (0,50) 
A.P 
(vol.%) 
B.D 
(g/cc) 
A.P 
(vol.%) 
B.D 
(g/cc) 
A.P 
(vol.%) 
B.D 
(g/cc) 
A.P 
(vol.%) 
B.D 
(g/cc) 
A.P 
(vol.%) 
B.D 
(g/cc) 
A.P 
(vol.%) 
B.D 
(g/cc) 
800 42.36 1.55 48.79 1.37 18.60 2.10 26.81 1.94 47.41 1.42 54.39 1.24 
850 41.86 1.58 45.43 1.42 18.14 2.16 26.67 1.95 46.49 1.45 53.25 1.27 
900 38.93 1.66 44.20 1.47 15.41 2.25 26.33 1.96 45.03 1.50 53.20 1.28 
On reviewing the consolidated results drafted in Table – 4.5, it had been confirmed that FGS 2P (0,30) 
attains better overall bulk density than the other FGS scaffolds. FGS 4P (0,50) performs as a highly 
porous scaffold when compared with other FGS scaffolds.   
4.13 APPARENT POROSITY & BULK DENSITY OF GRADED LAYERS 
The evaluation of apparent porosity and bulk density on each and every layer is mandatory for the 
characterization of functionally graded scaffolds. Three small regions from outer layer and inner layer 
had been cut and carved out. Then the apparent porosity and bulk density of those samples had been 
calculated. This evaluation clearly shows the gradient in porosity attained by uniaxial pressing and 
sintering method. In other words, the results obtained in the previous section can be called as effective 
Apparent Porosity and bulk density values of the graded layers. Fig – 4.14.1(a) & Fig – 4.14.1(b) shows 
the apparent porosity & bulk density of outer and inner layers of 45S5 (0,30) scaffold respectively. 
Without any drastic fall in apparent porosity, there was a gradual reduction in apparent porosities of 
outer and inner layers of 45S5 (030) scaffold. Table – 4.5 shows the corresponding tabulated results. 
Table – 4.7 Apparent Porosity & Bulk density of graded layers of 45S5 (0,30) 
Sintering 
Temperature 
(in °C) 
45S5 (0,30) – Outer Layer 45S5 (0,30) – Inner Layer 
Apparent Porosity 
(vol.%) 
Bulk Density 
(g/cc) 
Apparent Porosity 
(vol.%) 
Bulk Density 
(g/cc) 
800 32.16 1.82 52.33 1.250 
850 30.99 1.84 52.31 1.261 
900 29.64 1.89 52.21 1.262 
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Fig – 4.14.1(a) Apparent Porosity & Bulk density of Outer Layer of 45S5 (0,30) scaffold 
Fig – 4.14.1(b) Apparent Porosity & Bulk density of Inner Layer of 45S5 (0,30) scaffold 
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Fig – 4.14.2 (a) and Fig – 4.14.2(b) shows the apparent porosity and bulk density of outer and 
inner layers respectively of 45S5 (0,50) scaffold. The outer layer achieved a maximum bulk density of 
about 1.9g/cc and inner layer attains a bulk density of 1.28 g/cc at 900°C.  In the case of 45S5(0,50), 
pore reduction proceeds even till sintering temperature reaches 900°C. The densification of outer layer is 
comparatively less than the inner layer of 45S5 (050). Table 4.6 shows the Apparent porosity and bulk 
density values of graded layers of 45S5 (0,50).  
Table – 4.8 Apparent Porosity & Bulk density of graded layers of 45S5 (0,50) scaffold 
Sintering 
Temperature 
(in °C) 
45S5 (0,50) – Outer Layer 45S5 (0,50) – Inner Layer 
Apparent Porosity 
(vol.%) 
Bulk Density 
(g/cc) 
Apparent Porosity 
(vol.%) 
Bulk Density 
(g/cc) 
800 34.67 1.71 63.02 0.98 
850 32.15 1.81 61.54 1.01 
900 28.58 1.91 58.02 1.05 
Fig – 4.14.2(a) Apparent Porosity & Bulk density of Outer layer of 45S5 (0,50) scaffold 
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Fig – 4.14.2(b) Apparent Porosity & Bulk density of Inner layer of 45S5 (0,50) scaffold 
Fig – 4.14.3(a) & Fig – 4.14.3(b) shows the apparent porosity and bulk density of outer and inner 
layers of 2P (0,30) scaffold respectively. In the case of outer layer of 2P (0,30), the maximum pore 
reduction had been attained at 800°C and not much pore reduction had been observed when the sintering 
temperature proceeds to 850°C and 900°C. In the inner layer of 2P(0,30), maximum pore reduction took 
place within 850°C itself. Table – 4.7 shows the apparent porosity and bulk density values of graded 
layers of 2P (0,30) scaffold.  
Table – 4.9 Apparent Porosity & Bulk density of graded layers of 2P (0,30) scaffold 
Sintering 
Temperature 
(in °C) 
2P (0,30) – Outer Layer 2P (0,30) – Inner Layer 
Apparent Porosity 
(vol.%) 
Bulk Density 
(g/cc) 
Apparent Porosity 
(vol.%) 
Bulk Density 
(g/cc) 
800 5.77 2.46 54.15 1.15 
850 3.95 2.47 48.73 1.76 
900 3.13 2.55 34.10 1.34 
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Fig – 4.14.3(a) Apparent Porosity & Bulk density of Outer layer of 2P (0,30) scaffold 
Fig – 4.14.3(b) Apparent Porosity & Bulk density of Inner layer of 2P (0,30) scaffold 
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Fig – 4.14.4 (a) & Fig – 4.14.4(b) shows the Apparent porosity and bulk density of outer 
and inner layers of 2P (0,50) respectively. At 800°C, a large amount of pore reduction had been carried 
out in the outer layer. But at the same time, pore reduction had been continued till the sintering 
temperature reaches 900°C for inner layer. The apparent porosity and bulk density values of graded 
layers of 2P(0,50) with corresponding temperature had been drafted in the table – 4.8. 
Table – 4.10 Apparent Porosity & Bulk density of graded layers of 2P (0,50) scaffold 
Sintering 
Temperature 
(in °C) 
2P (0,50) – Outer Layer 2P (0,50) – Inner Layer 
Apparent Porosity 
(vol.%) 
Bulk Density 
(g/cc) 
Apparent Porosity 
(vol.%) 
Bulk Density 
(g/cc) 
800 3.49 2.41 49.85 1.28 
850 2.68 2.55 34.43 1.71 
900 1.95 2.60 32.98 1.77 
. 
Fig – 4.14.4(a) Apparent Porosity & Bulk density of Outer layer of 2P (0,50) scaffold 
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Fig – 4.14.4(b) Apparent Porosity & Bulk density of Inner layer of 2P (0,50) scaffold 
Fig – 4.13.5(a) and Fig – 4.13.5(b) shows the apparent porosity and bulk density of outer and inner layer 
of 4P(0,30) respectively. The outer bone layer registered apparent porosity within the range of 36vol.% 
to 38vol.%, which is the highest among the outer bone layers of 45S5 (030) and 2P (030). A gradual 
increase in bulk density had been attained when the temperature increases from 800°C to 900°C.
Table – 4.9 illustrates the corresponding apparent porosity and bulk density values of graded layers of 
4P(0,30) scaffold.  
Table – 4.11 Apparent Porosity & Bulk density of graded layers of 4P (0,30) scaffold 
Sintering 
Temperature 
(in °C) 
4P (0,30) – Outer Layer 4P (0,30) – Inner Layer 
Apparent Porosity 
(vol.%) 
Bulk Density 
(g/cc) 
Apparent Porosity 
(vol.%) 
Bulk Density 
(g/cc) 
800 37.86 1.66 53.27 1.25 
850 37.82 1.68 51.96 1.26 
900 36.68 1.72 50.72 1.29 
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Fig – 4.14.5(a) Apparent Porosity & Bulk density of Outer layer of 4P (0,30) scaffold 
Fig – 4.14.5(b) Apparent Porosity & Bulk density of Inner layer of 4P (0,30) scaffold 
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Fig – 4.14.6(a) and Fig – 4.14.6(b) shows the apparent porosity and bulk density of outer and inner layer 
of 4P(0,50) respectively. 4P (050) had been considered to be the highly porous scaffolds among the 
other scaffolds. 52 to 64 vol.% and 38 to 42 vol.% of apparent porosity had been attained with the outer 
and inner layers respectively. A drastic decrease in apparent porosity had been observed on the inner 
layer, when the temperature increases from 800°C to 850°C. Table – 4.10 illustrates the apparent 
porosity and bulk density values of graded layers of 4P(0,50) scaffold.  
Table – 4.12 Apparent Porosity & Bulk density of graded layers of 4P (0,50) scaffold 
Sintering 
Temperature 
(in °C) 
4P (0,50) – Outer Layer 4P (0,50) – Inner Layer 
Apparent Porosity 
(vol.%) 
Bulk Density 
(g/cc) 
Apparent Porosity 
(vol.%) 
Bulk Density 
(g/cc) 
800 41.93 1.55 64.16 0.88 
850 41.16 1.60 53.17 1.10 
900 38.98 1.61 52.32 1.13 
Fig – 4.14.6(a) Apparent Porosity & Bulk density of Outer layer of 4P (0,50) scaffold 
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Fig – 4.14.6(b) Apparent Porosity & Bulk density of Inner layer of 4P (0,50) scaffold 
4.14 COMPARATIVE STUDY OF SINGLE LAYER AND FUNCTIONALLY GRADED 
SCAFFOLDS – Apparent Porosity & Bulk density 
Single layer porous scaffolds had been fabricated on addition of 0wt.%, 30wt.% & 50wt.% 
naphthalene which had been represented as 0P, 30P & 50P respectively. As given in the table – 3.2, two 
types of functionally graded scaffolds – (0,30) and (0,50) had been prepared. The Outer layer (without 
pore former – 0wt.%) of the functionally graded scaffolds and 0P – single layer scaffolds resembles with 
same composition. Similarly, the inner layer (30wt.% & 50wt.%) depicts the similar composition of the 
single layer scaffolds – 30P & 50P. Single layer scaffold compositions had been uniaxial pressed and 
sintered. But the functionally graded scaffolds are co-compacted and co-sintered with outer and inner 
layer compositions. Even the compositions of the single layer scaffolds resemble with the composition 
of the graded layers, the compaction and sintering environments are different. Comparing the properties 
of single layer scaffolds with graded layers of functionally graded scaffolds fetches a better 
understanding of sintering behavior of functionally graded scaffolds. In this section, the apparent 
porosity and bulk density of single layer scaffolds and graded layers had been compared.    
Fig – 4.15.1 illustrates the apparent porosity and bulk density of 45S5 (0,30), 45S5(0P) & 45S5(30P).  
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T E M P E R A T U R E    ( ° C ) 
T E M P E R A T U R E    ( ° C ) 
Fig – 4.15.1      Graded Layers of 45S5(0,30) vs 45S5(0P) & 45S5(30P) 
Apparent Porosity of Outer Layer of 45S5 (030) FGS is comparatively less than the 45S5(0P). 
Apparent Porosity of Inner Layer of 45S5 (030) FGS is comparatively less than the 45S5(30P). 
Difference in Apparent porosities of Inner Layer of 45S5 (030) FGS and 45S5(30P) is too high when 
compared with the difference in Apparent porosities of Outer Layer of 45S5 (030) FGS and 45S5(0P).  
Fig – 4.15.2 illustrates the apparent porosity and bulk density of the graded layers of 45S5 (0,50), 
45S5(0P) & 45S5(50P).   
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T E M P E R A T U R E    ( ° C ) 
T E M P E R A T U R E    ( ° C ) 
Fig – 4.15.2      Graded Layers of 45S5(0,50) vs 45S5(0P) & 45S5(50P) 
Apparent Porosity of Outer Layer of 45S5 (050) FGS is higher than the 45S5 (0P) for the scaffolds 
sintered at 800°C & 850°C. But there was a drastic decrease in the Apparent Porosity of Outer Layer of 
45S5 (050) FGS, when they had sintered at 900°C. This drastic decrease recorded a lower Apparent 
Porosity than the 45S5 (0P). Apparent porosity of Inner Layer of 45S5 (050) FGS is relatively lower 
than the 45S5 (50P) scaffolds. From 800°C to 850°C, there was a linear decrease in apparent porosity. 
But at 900°C, a huge reduction in apparent porosity of Inner Layer of 45S5 (050) FGS & 45S5 (50P) 
had been observed.  
Fig – 4.15.3 illustrates the apparent porosity and bulk density of 2P (0,30), 2P(0P) & 2P(30P). 
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T E M P E R A T U R E    ( ° C ) 
T E M P E R A T U R E    ( ° C ) 
Fig – 4.15.3      Graded Layers of 2P(0,30) vs 2P(0P) & 2P(30P) 
A gradual decrease in Apparent porosity had been observed for Outer Layer of 2P (030) FGS and 2P 
(0P), when sintered from 800°C to 900°C. The bulk density for Outer Layer of 2P (030) FGS and 2P 
(0P) were almost similar when sintered at 900°C. A drastic decrease in Apparent porosity of Inner Layer 
of 2P (030) FGS had been observed when sintered from 800°C to 850°C. Then a linear reduction of 
apparent porosity had been observed on the Inner layer of 2P (030) when fired at 900°C. 
A linear reduction of apparent porosity had been observed for 2P (30P) from 800°C to 900°C.  Similar 
phenomena had been observed in the bulk density of 2P(30P) and Inner layer of 2P (030) FGS.  
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T E M P E R A T U R E    ( ° C ) 
T E M P E R A T U R E    ( ° C ) 
Fig – 4.15.4      Graded Layers of 2P(0,50) vs 2P(0P) & 2P(50P) 
Fig – 4.15.4 illustrates the apparent porosity and bulk density of 2P (0,50), 2P(0P) & 2P(50P). From 
800°C to 850°C, gradual reduction in apparent porosity for Outer Layer of 2P (050) had been attained. 
But the rate of reduction in apparent porosity had been reduced, when the temperature proceeds to 
900°C. The apparent porosity of 2P (0P) is comparatively less than the outer layer of the 2P (050) FGS. 
At sintering temperatures 800°C & 850°C, the apparent porosity for Inner Layer of 2P (050) was 
relatively high than the 2P (50P) scaffold. But at 900°C, a drastic decrease in apparent porosity of Inner 
Layer of 2P (050) had been noticed whose apparent porosity is less than the 2P (50P). 
A
 P
 P
 A
 R
 E
 N
 T
  
  
 P
 O
 R
 O
 S
 I
 T
 Y
  
  
 (
 V
 O
 L
 .
 %
 )
 
B
 U
 L
 K
    D
 E
 N
 S
 I T
 Y
     ( g
 / c
 . c
 ) 
104 
T E M P E R A T U R E    ( ° C ) 
T E M P E R A T U R E    ( ° C ) 
Fig – 4.15.5      Graded Layers of 4P(0,30) vs 4P(0P) & 4P(30P) 
Fig – 4.15.5 illustrates the apparent porosity and bulk density of 4P (0,30), 4P(0P) & 4P(30P). 
The apparent porosity of the FGS parts are less when compared with the Single layer scaffolds – 4P (0P) 
& 4P (30P) on all temperatures. Similar characteristic feature had been observed on all the cases. 
Fig – 4.15.6 illustrates the apparent porosity and bulk density of 4P (0,50), 4P(0P) & 4P(50P).The 
graded parts had attained less apparent porosity when compared to the single layer scaffolds – 4P (0P) & 
4P (50P).  
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T E M P E R A T U R E    ( ° C ) 
T E M P E R A T U R E    ( ° C ) 
Fig – 4.15.6      Graded Layers of 4P(0,50) vs 4P(0P) & 4P(50P) 
A drastic decrease in the reduction of apparent porosity had been observed on the graded parts, 
from 800°C to 850°C. When the temperature proceeds to 900°C, the linear reduction of apparent 
porosity had been attained. The oscillation had not been seen with the single layer scaffolds - 4P (0P) & 
4P (50P).  
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4.15 FUNCTIONALLY GRADED MICROSTRUCTURES 
On reviewing the results of apparent porosity and bulk density, it had been decided that optimum 
porosity and density is required for functionally graded scaffold. Thus the intermediate sintering 
temperature of 850°C had been fixed for the further characterization of the current work. The interface 
joining the outer and inner layer of the functionally graded scaffold is the critical point of the fabrication 
technique, on post sintering. In order to view the interface, it is necessary to take microstructures with 
least magnification. From the fabricated scaffolds, the samples had been cut in such a way that both 
dense (outer layer) and the porous (inner layer) regions are present. Fig – 4.16.1, Fig – 4.16.2, Fig – 
4.16.3, Fig – 4.16.4, Fig – 4.16.5 & Fig – 4.16.6 shows the SEM microstructures of the 45S5(0,30), 
45S5(0,50), 2P(0,30), 2P(0,50), 4P(0,30) and 4P(0,50) graded scaffolds, which had been sintered at 
850°C. 
Fig – 4.16.1 SEM Microstructures of 45S5(0,30) scaffolds sintered at 850°C 
Fig – 4.16.1 shows the SEM microstructures of 45S5(030) at 850°C. In order to possess clear 
microstructure showing the interface, dense and porous regions, these kinds of microstructures had been 
taken with 1mm and 500μm scale.   
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Fig – 4.16.2 SEM Microstructures of 45S5(0,50) scaffolds sintered at 850°C 
The Fig – 4.16.2 shows the microstructures of 45S5 (050) functionally graded scaffold. Including the 
microstructure of 45S5 (030) , the porous region seems to be fibrous like structure. These samples had 
been carved out from the center region of the FGS.  
Fig – 4.16.3 SEM Microstructures of 2P(0,30) scaffolds sintered at 850°C 
Fig – 4.16.3 shows the SEM microstructure of 2P(030) scaffold. Since the sintering behavior of 2P 
based scaffolds are better than the 45S5 and 4P, the interface is perfectly is joined without any major 
cracks.  
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Fig – 4.16.4 SEM Microstructures of 2P(0,50) scaffolds sintered at 850°C 
The microstructure of the cross section of 2P (030) looks prominent in pore arrangement. In the case of 
2P(050), the porous and dense region merges and makes it undistinguishable. This may be due to larger 
shrinkage, as pore former is deliberately high.     
Fig – 4.16.5 SEM Microstructures of 4P(0,30) scaffolds sintered at 850°C 
Due to restricted densification, the 4P(030) microstructure shows the irregular arrangement of pore 
compared with the other scaffolds. Even though the interface is joined well, due to insufficient 
densification, weak interface will be formed.  
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Fig – 4.16.6 SEM Microstructures of 4P(0,50) scaffolds sintered at 850°C 
As per the microstructure of 4P(050), the pore size is quite large when compared with other 
microstructures of functionally graded scaffolds. As per the Apparent porosity and bulk density results, 
4P (050) are highly porous scaffolds which is clearly evident with the microstructure. Some of the other 
microstructures of 45S5, 2P & 4P based functionally graded scaffolds, which had been sintered at 
850°C, which had been taken from different regions of the scaffolds had been illustrated in Fig – 4.16.7, 
Fig – 4.16.8 & Fig – 4.16.9 respectively.  
Fig – 4.16.7 (a) 45S5 based functionally graded microstructures 
45S5 (0,30) 
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Fig – 4.16.7 (b) 45S5 based functionally graded microstructures 
Fig – 4.16.7 (a) shows the microstructure of 45S5 (030) FGS. It clearly illustrates the longitudinal 
section of the interface between dense and porous region.  
 Fig – 4.16.8  2P based functionally graded microstructures 
Fig – 4.16.8 shows the microstructures of 2P (050) scaffolds. The pore population and pore channel 
morphology can be clearly seen on these microstructures.  
45S5 (0,50) 45S5 (0,50) 
2P (0,50) 
2P (0,50) 
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Fig – 4.16.9 4P based functionally graded microstructures 
4.16 BRAZILIAN DISC ANALYSIS 
The architecture of the scaffold is functionally graded, with dense layer at the outer region and porous 
layer at the inner region. As mentioned earlier in the section 3.16, splitting tensile strength is measured 
for gradient microstructures, as per the theory of rock mechanics. During tensile strength measurement 
on functionally graded scaffolds, the applied continuous uniaxial loading instigates the propagated crack 
to travel from outer - dense region to the inner - porous region. Since the scaffolds were not isotropic, 
the measured tensile strength is called us splitting tensile strength [69]. 
Splitting tensile strength of the functionally graded scaffolds had been evaluated by making a Brazilian 
disc specimen and undergoing Brazilian Disc analysis. The functionally graded scaffolds, which had 
been sintered at 850°C, had been cut with a diamond tool to make Brazilian disc specimen as shown in 
the Fig – 4.17.1.  
On the Brazilian disc specimen, uniaxial loading had been given as per the specifications mentioned in 
the section 3.16. When the uniaxial loading is given, the applied force increases continuously. When the 
crack originates within the specimen, the applied force drops and the propagated crack travels from the 
dense region, further enters the porous region. 
4P (0,50) 
4P (0,30) 
112 
Fig – 4.17.1 Functionally graded scaffolds as Brazilian disc specimens 
After crossing the porous region, when the crack reaches the dense region, the applied force again tends 
to increase. Once the specimen is completely fractured, the applied force again drops. This kind of 
phenomena had been noticed with the functionally graded – Brazilian disc specimens. Fig – 4.17.2 
shows the fractured Brazilian disc specimens.  
Fig – 4.17.2 Fractured functionally graded - Brazilian Disc specimens 
After the uniaxial loading of the functionally graded - Brazilian disc specimens, different ranges of 
fractures had been encountered. But a common scenario had been encountered within the specimens in 
terms of cracks.  
4P (050) 4P (030) 2P (050) 
2P (030) 
45S5 (050) 
45S5 (030) 
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The Brazilian disc specimens with low amount of porosity in the inner layer, (i.e) (030) based scaffolds, 
propagates the cracks within the region of central diameter of the specimen. The specimen with high 
amount of porosity, (i.e) (050) based scaffolds, tends to get fractured in irregular modes.  
Fig – 4.17.3 illustrates the Force vs. Extension curve evolved during the uniaxial loading on functionally 
graded Brazilian disc specimens.  
Fig – 4.17.3 Force vs. Extension curves on Fractured functionally graded - Brazilian Disc 
specimens 
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From the Force vs. Extension curves, the peak load had been noted and the splitting tensile strength of 
the functionally graded scaffolds had been calculated as given in the section 3.16. The average disc 
diameter had been calculated from the three diameters marked in the Fig – 4.17.4.  
Fig – 4.17.4 Measurement of Average Brazilian Disc diameter 
As per the formula mentioned in the section 3.16, the splitting tensile strength of the functionally graded 
Brazilian disc specimens had been calculated. The test results of the Brazilian disc analysis had been 
tabulated in the table – 4.11. 
Table – 4.11 Brazilian disc analysis of functionally graded scaffolds 
S.No: FGS Scaffolds Applied Peak Load 
(N) 
Average Disc 
Diameter (mm) 
Splitting Tensile 
Strength (MPa) 
1. 45S5 (0,30) 1662 26.84 6.15 
2. 45S5 (0,50) 350 26.91 1.31 
3. 2P (0,30) 1434 24.87 6.59 
4. 2P (0,30) 776 24.80 3.69 
5. 4P (0,30) 636 26.86 2.13 
6. 4P (0,50) 238 26.79 0.81 
The splitting tensile strength is purely based on the average diameter of brazilian disc specimen obtained 
apart from the applied peak load. For a better comparative study, within the scaffolds, the evaluated 
splitting tensile strength had been plotted in the Fig – 4.17.5.  
1 2
3
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FUNCTIONALLY GRADED SCAFFOLDS 
Fig – 4.17.5 Splitting Tensile Strength of Functionally graded scaffolds (sintered at 850°C) 
2P (0,30) attained high tensile strength than the other functionally graded scaffolds. 45S5 (0,30) possess 
a tensile strength much close to 2P (0,30) scaffolds. The high porous 2P(0,50) is stronger than both 
4P(0,30) and 4P(0,50).  
4.17 COMPARATIVE STUDY OF SINGLE LAYER AND FUNCTIONALLY GRADED 
SCAFFOLDS – Tensile Strength 
In the section 4.14, the apparent porosity and bulk density of single layer scaffolds and functionally 
graded scaffolds had been compared and discussed. As mentioned earlier, since the composition of 
single layer bioactive glass ceramic scaffolds (with or without pore former) occupies a layer in 
functionally graded bioactive glass ceramic scaffolds, the comparison becomes fruitful. It is appropriate 
to study the performance of a particular bioactive glass ceramic composition, which occupies a region in 
single layer and functionally graded scaffolds. As similar to the section – 4.14, in this section, the tensile 
strength of the single layer and layers of functionally graded scaffolds had been compared.  
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Fig – 4.18 Comparison of Tensile Strength of Single Layer Scaffolds and Functionally graded 
scaffolds 
Fig – 4.17.1 illustrates the comparison of tensile strength of single layer scaffolds and functionally 
graded scaffolds. The 45S5 based functionally graded scaffolds, (i.e) 45S5(030) and 45S5(050) 
scaffolds, bears tensile strength better than the porous single layer scaffolds - 45S5 30P and 45S5 50P 
respectively. This shows that during sintering of functionally graded scaffolds, the bonding between the 
outer layer and the inner layer are strong.  Fig – 4.14.1 clearly illustrates that the bulk density of Inner 
Layer of 45S5 (030) scaffold is better than the bulk density of 45S5 30P. Similarly, the bulk density of 
outer layer of 45S5 (030) is better than the bulk density of 45S5 0P. This shows that the outer layer 
shrinks and acts as a driving force for the shrinkage of inner layer. When the porosity is increased in the 
inner layer, (i.e) the 45S5 (050), the bulk density of 45S5 0P and outer layer of 45S5 (050) are more or 
less same.  
117 
But the inner layer of 45S5 (050) and 45S5 50P retains the similar behavior of 45S5 30P and inner layer 
of 45S5 (030). These types of architectural considerations had reflected on the corresponding tensile 
strength of the scaffolds.  As mentioned earlier in the section - 4.3, due to low amount of P2O5 in 2P 
glass composition, the degree of polymerization of Si-network decreases. This leads to undergo actual 
densification mechanism at the low temperature itself. Since the process of densification starts early and 
takes a long to time to end, the impact of differential shrinkage had been neutralized. At the same time, 
since there is no interruptions of differential shrinkage in single layer scaffolds, better densification 
mechanism had been carried out. This is the reason for the porous single layer scaffolds - 2P 30P and 2P 
50P, which attains better tensile strength than 2P (030) and 2P (050) scaffolds.     
In the case of 4P based scaffolds, the amount of P2O5 is 4wt.%, which provides an intermediate 
performance between 2P and 45S5 based scaffolds. Due to the similar phenomena of degree of 
polymerization, 4P based scaffolds starts the densification mechanism even before 45S5 based scaffolds. 
This lengthy densification mechanism was capable to handle the differential shrinkage interruptions of 
4P (030) but not 4P (050). It requires some more time for the sintering of 4P (050). That’s the reason, 4P 
30P attains better tensile strength than 4P (030). Due to less efficiency in controlling differential 
shrinkage issues of highly porous scaffold – 4P (050), 4P 50P is stronger than 4P (050).  
4.18 INVITRO ANALYSIS OF FGS BY USING SBF 
The functionally graded scaffolds, 45S5 (050), 2P(050) & 4P(050), which had been sintered at 850°C, 
had been immersed as mentioned in the section 3.17. The immersed scaffolds had been undergone 
surface phase analysis and microstructure analysis to ensure the formation of carbonated hydroxyapatite. 
Fig – 4.19.1(a), Fig – 4.19.1(b) & Fig – 4.19.1(c) shows the microstructures of 45S5 (050) scaffolds 
immersed after 1 day, 7 days and 14 days of incubation respectively. After one day of immersion, 
spherical shaped carbonated hydroxyapatite particles had been deposited on the surface of the
45S5 (050) FGS [Fig – 4.19.1(a)]. Fig – 4.19.1(a) – 1 shows the porosity gradient functionally graded 
structure of 45S5 (050) FGS. Fig – 4.19.1(a) – 2, Fig – 4.19.1(a) – 3, Fig – 4.19.1(a) – 4 &
Fig – 4.19.1(a) – 7 shows the spherical particle morphology and Fig – 4.19.1(a) – 5 shows the deposition 
on the porous region.  
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Fig – 4.19.1 (a) Microstructures of 45S5 (050) immersed in SBF for 1 day incubation 
These spherical particles are the functional morphology for the development of carbonated 
hydroxyapatite formation. Fig – 4.19.1 (b) shows the Microstructures of 45S5 (050) FGS immersed in 
SBF for 7 days.  
1 2 3 
4 5 6 
7 
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 Fig – 4.19.1 (b) Microstructures of 45S5 (050) immersed in SBF for 7 days incubation 
Fig – 4.19.1 (b) Microstructure of 45S5(050) FGS immersed in SBF for 7 days. Fig – 4.19.1(b) – 1 
shows the functionally graded microstructure. After 7 days of immersion, the spherical particle tends to 
get fused with each other. This kind of mechanism had been observed after 7 days of immersion. Fig – 
4.19.1(b) – 2&3 shows the fused particles on the dense region. Fig – 4.19.1(b) – 4&5 shows the fused 
particle deposition on the porous region. Fig – 4.19.1 (c) shows the microstructures of 45S5 (050) 
immersed in SBF for 14 days.  
1 
2 3 
4 5 
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Fig – 4.19.1 (c) Microstructures of 45S5 (050) immersed in SBF for 14 days incubation 
Fig – 4.19.1 (c) – 1 shows the microstructure of gradient state of 45S5 (050) scaffold after immersion.  
Fig – 4.19.1 (c) – 2 shows the carbonated hydroxyapatite deposition on the dense region of FGS.
Fig – 4.19.1 (c) – 3 shows the carbonated hydroxyapatite deposition on the porous region of FGS.
Fig – 4.19.1 (c) – 4 shows the morphology of the deposited carbonated hydroxyapatite.  
1 2 
3 4 
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Fig – 4.19.2 (a) shows the microstructure of 2P(050) scaffold immersed in SBF for 1 day. 
Fig – 4.19.2(a) Microstructures of 2P (050) immersed in SBF for 1 day incubation 
4.19.2(a) – 1 shows the 2P(050) gradient structure of 2P(050) immersed in SBF for 1 days. 4.19.2(a) – 2 
shows minimum deposition as spherical particles. The morphology of those deposition is not prominent 
as observed with 45S5 (050) FGS immersed in SBF for 1 day. 4.19.2(b) shows the microstructures of 
2P(050) immersed in SBF for 4 days.  
Fig – 4.19.2(b) Microstructures of 2P (050) immersed in SBF for 4 days incubation 
Fig – 4.19.2 (b) – 1 shows the functionally graded structure. Fig – 4.19.2 (b) – 2 shows that no major 
development in the morphology of the deposition on the dense region of FGS. Fig – 4.19.2 (b) – 3 shows 
the deposition on the porous region of FGS 
1 2 
1 2 3 
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.   Fig – 4.19.2(c) Microstructures of 2P (050) immersed in SBF for 7 days incubation 
Fig – 4.19.2 (c) shows the microstructures of 2P (050) FGS immersed in SBF for 7 days. No further 
development from the previous interval had been on these microstructures. Fig – 4.19.2 (c) -1 shows the 
gradient nature of the scaffold. Fig – 4.19.2 (c) – 2 shows the deposition on the dense region of FGS. Fig 
– 4.19.2 (c) – 3 shows the deposition on the porous region of the FGS.
Fig – 4.19.2(d) Microstructures of 2P (050) immersed in SBF for 14 days incubation 
Fig -4.19.2 (d) shows the microstructures of 2P(050) immersed in SBF for 14 days. Fig -4.19.2(d) – 2 
shows the deposition on the dense region of the scaffold. Fig -4.19.2(d) – 3 shows the deposition on the 
porous region of the scaffold. Carbonated Hydroxyapatite formation is not evident with the 
microstructures even after immersion in SBF for 14 days. But the spherical particles indicates that they 
are in the under developed stage of carbonated hydroxyapatite. 
Fig -4.19.3 illustrates the microstructures of 4P(050) immersed in SBF for 1,4,7 &14 days. 
1 2 3 
1 2 
3 
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Fig – 4.19.3(a) Microstructures of 4P (050) immersed in SBF for 1 day incubation 
Fig – 4.19.3 (a) shows the microstructure of 4P(050) FGS immersed in SBF for 1 day. Fig – 4.19.3 (a) – 
1 show the graded layers of the scaffolds immersed. Fig – 4.19.3 (a) – 1 shows the deposition on the 
dense region and Fig – 4.19.3 (a) – 2 shows the deposition on the porous region of the scaffold. Some 
fused particles had been deposited on the surface of the scaffold.  
Fig – 4.19.3(b) Microstructures of 4P (050) immersed in SBF for 4 days incubation 
Fig – 4.19.3(b) shows the microstructure of 4P(050) immersed in SBF for 4 days. Fig – 4.19.3(b) – 1 
shows the gradient structure of the scaffold immersed in SBF. Fig – 4.19.3(b) – 2 shows the deposition 
on the dense region of the scaffold. Fig – 4.19.3(b) – 3 shows the deposition on the porous region of the 
scaffold. With minimal deposition and no major development had been observed.  
Fig – 4.19.3(c) shows the microstructure of 4P(050) immersed in SBF for 7 days. 
1 
3 
1 
2 
2 3 
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Fig – 4.19.3(c) Microstructures of 4P (050) immersed in SBF for 7 days incubation 
Fig – 4.19.3(c) - 1 shows the microstructure of 4P(050) gradient nature. Fig – 4.19.3(c) – 2 shows the 
deposition on the dense region and Fig – 4.19.3(c) – 3 shows the deposition on the porous region. This 
microstructure shows the under developed stage of carbonated hydroxyapatite formation.  
Fig – 4.19.3(d) Microstructures of 4P (050) immersed in SBF for 14 days incubation 
Fig – 4.19.3(d) shows the microstructure of 4P(050) FGS immersed in SBF for 14 days. There is no 
traces of development and retains in the previous interval of observation. Fig – 4.19.3(d) – 1 shows the 
gradient nature of the 4P(050) after immersion. Fig – 4.19.3(c) – 2 shows the deposition on the porous 
cavity of the scaffold. Fig – 4.19.3(d) – 3 shows the microstructure of deposition on the dense region of 
the scaffold. To determine the phases formed on the surface of the scaffold, XRD analysis of the SBF 
soaked had been carried out. Fig – 4.19.4 shows XRD analysis of SBF soaked 45S5 (050) scaffolds.  
1 2 3 
1 
2 3 
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Fig – 4.19.4 (a) Surface phase analysis of SBF immersed 45S5 (050) scaffolds 
Fig -4.19.4 (a) shows the surface phase analysis of 45S5 (050) scaffolds immersed in SBF for 1, 4, 7 & 
14 days. After first day of immersion, a minor trace of carbonated hydroxyapatite phase had been 
identified. On the fourth day, the surface of the 45S5 scaffold becomes amorphous due to the formation 
of amorphous calcium phosphate. Due to crystallization, after 7 days of immersion, carbonated 
hydroxyapatite phase is formed. After 14 days of immersion, the carbonated hydroxyapatite phase is 
predominantly distributed all over the surface of the 45S5 (050) scaffold.  The carbonated 
hydroxyapatite - Ca10(PO4)3(CO3)3(OH)2 had been matched by the JCPDS pattern 19-0272.  
Ο Carbonated HAP - Ca10(PO4)3(CO3)3(OH)2  
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Fig – 4.19.4 (b) Surface phase analysis of SBF immersed 2P (050) scaffolds 
Fig – 4.19.4 (b) shows the phase analysis of SBF soaked 2P (050) scaffolds. The carbonated 
hydroxyapatite phase had originated after 4 days of immersion in SBF. The phase after the 4
th
 day of
immersion shows partial amorphous calcium phosphate formation. After 7 days of immersion, there is 
no development in the growth and regeneration, which results with a minor phase of carbonated 
hydroxyapatite phase. After 14 days of immersion, the carbonated hydroxyapatite phase had been 
increased, but still it is in the development stage. The carbonated hydroxyapatite - 
Ca10(PO4)3(CO3)3(OH)2 had been matched by the JCPDS pattern 19-0272.  
Fig – 4.19.4 (c) shows the phase analysis of SBF soaked 4P (050) scaffolds. 
Ο Carbonated HAP - Ca10(PO4)3(CO3)3(OH)2  
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Fig – 4.19.4 (c) Surface phase analysis of SBF immersed 4P (050) scaffolds 
Fig – 4.19.4 (c) shows the surface phase analysis of SBF immersed 4P(050) scaffolds. After first day of 
immersion, minor phase of carbonated hydroxyapatite phase had been formed. Partial amorphous 
calcium phosphate formation is evident after the first day of immersion. After 4 days, there is no 
development or growth of phase had been formed. The carbonated hydroxyapatite - 
Ca10(PO4)3(CO3)3(OH)2 had been matched by the JCPDS pattern 19-0272.  
On an overall comparison, 45S5 based functionally graded scaffolds shown highly matured carbonated 
hydroxyapatite morphology in its microstructure, at the end of 14 days, in invitro - SBF analysis. 
Whereas the growth of the carbonated hydroxyapatite on 4P and 2P based scaffolds is not distinctly 
evident as in 45S5. The phase analysis had shown the deposition of carbonated hydroxyapatite on all the 
three glass compositions.  
Ο Carbonated HAP - Ca10(PO4)3(CO3)3(OH)2  
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O.Peitl et al [78] had clearly illustrated that amount of phosphate ions present in the solid solution 
(during invitro analysis) plays the vital role on the rate of Carbonated Hydroxyapatite deposition. Hence 
due to insufficient P2O5, we can conclude that carbonated hydroxyapatite formation on 4P and 2P based 
scaffolds are immature or it can be said that they are under development.     
4.19 INVITRO ANALYSIS ON FGS BY USING MG-63 CELL LINE 
MG-63 cells had been seeded on the functionally graded scaffolds to determine cell viability and cell 
adherence. By using MTT Assay, the cell viability on the FGS had been determined.  
Fig – 4.20 (a) MG – cell seeded FGS after addition of MTT Assay 
When the MTT Assay is added on the cell seeded scaffolds, due to mitochondrial reductase, farmazon 
compounds had been formed, which had been indicated by blue color precipitates on the scaffolds. Since 
the farmazon compound formation had been initiated by the viable mitochondria, the optical densities of 
the farmazon compounds are directly proportional to the viable cells. Fig – 4.20 (a) shows the condition 
of the MG- 63 cell seeded scaffold after addition of MTT Assay. The blue color intensity is 
predominantly high in the porous region than the dense region. This clearly shows that the cell viability 
is more in the porous region than the dense region of the FGS. In the biological systems, cell 
proliferation is restricted on the cortical bone layer; rather it provides attachment points for the 
adsorption of proteins and other biomolecules. The cancellous bone layer provides feasibility for cell 
proliferation and cell growth due highly porous architecture. The same scenario had been depicted with 
this FGS. The effective cell viability of entire FGS had been evaluated and illustrated in Fig – 4.20 (b).  
POROUS 
REGION 
DENSE 
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Fig – 4.20 (b) Cell viability of functionally graded scaffolds 
All the functionally graded scaffolds showed cell viability less than the control. This is due to the 
restriction cell movement through the dense region. 2P (050) scaffold survived with more or less equal 
amount of viable cells. But in the case of 4P (050) scaffold, it had shown less cell viability than the 
others. The phase contrast microscopic images of cell seeded scaffolds had been illustrated in fig – 4.20 
(c). 
Fig – 4.20 (c) Phase contrast images of MG-63 cell seeded FGS 
CONTROL 45S5 (050) FGS 
2P (050) FGS 
4P (050) FGS 
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Fig – 4.20 (d) SEM images of MG-63 cell seeded 45S5(050) FGS 
1 2 
3 4 
5 6 
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After incubation for 1 day, the MG-63 cell seeded functionally graded scaffolds had been fixed with 
glutraldehyde. Fig – 4.20(d) shows the SEM images of cell seeded on 45S5 (050) scaffolds. These 
microstructures show that the cells are adhered perfectly on the surface of the scaffolds. The Fig-4.20(d) 
-1 shows the penetration of cells into the pores. Fig-4.20(d) -2 depicts the development of tail and 
attaching itself via the circumference of the pore. Fig-4.20(d) -3 shows the cell adherence on the dense 
surface of the scaffold. Fig-4.20(d) -4 shows the cells entering the pore interconnectivity. Fig-4.20(d) -5 
& Fig-4.20(d) – 6 shows the cell to cell attachment within the pores.  
 Fig – 4.20 (e) FESEM images of MG-63 cell seeded 45S5(050) FGS 
1 2 
3 4 
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Fig – 4.20 (f) FESEM image of MG-63 cell travelling into the pores of 45S5(050) FGS 
Fig – 4.20 (e) - 1 shows the FESEM image of MG-63 cell seeded 45S5 (050) FGS. Fig – 4.20 (e) – 2 
shows the cells adhered on the rough surface of the scaffolds. Fig – 4.20 (e) – 3 shows the spherical and 
elongated cells adhered on the dense region.  Fig – 4.20 (e) – 4 shows the cells trying to enter into the 
pores of the scaffold. Fig – 4.20 (f) depicts the cells travelling into the pore cavity. These 
microstructures clearly illustrates that the architecture of the scaffolds had not interrupted the cell 
movement. Due to the high biocompatible environment provided by the scaffold, pronounced cell 
adherence and cell movements had been observed.   
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4.20 CONCLUSIONS 
In this present work, three bioactive glass compositions had been taken namely 45S5 (6wt. % P2O5), 2P 
(2wt. % P2O5) and 4P (4wt. % P2O5). These bioactive glass compositions had been prepared by using 
melt quench method. For the first time, Functionally graded scaffolds had been prepared with these 
bioactive glass compositions by using simple uniaxial pressing and sintering method. The architecture of 
the functionally graded bioactive glass ceramic scaffolds had been designed in such a way that the 
porous region and the dense region are at the center and the periphery respectively.    
Before evaluating the performance of functionally graded bioactive glass ceramic scaffolds, each 
bioactive glass compositions had been fabricated as single layer – dense and single layer - porous 
scaffolds. By using Naphthalene as a pore former (0 wt.%, 30 wt.% and 50 wt.%) the single layer 
scaffolds had been uniaxial pressed and sintered at 800°C, 850°C and 900°C. Apparent Porosity, Bulk 
density, diametral tensile strength and flexural strength had been evaluated for single layer porous 
bioactive glass ceramic scaffolds. Then the functionally graded bioactive glass ceramic scaffolds had 
been prepared by uniaxial pressed and sintered at 800°C, 850°C and 900°C. During the course of the 
fabrication and characterization of single layer and FGS, the following conclusions had be made: 
 The melt derived bioactive glasses – 45S5, 2P and 4P had undergone DSC-TG analysis. It had been
observed from the thermal analysis that when the amount of P2O5 increases, the proportion of Q3
species had also increases, which results in pronounced crystallization.
 The sintering behavior of 45S5, 2P and 4P bioactive glass compacts had been investigated by
dilatometric analysis. The degree of polymerization aroused early on 2P bioactive glass than the
other two bioactive glass compositions, which results in better densification for 2P than 45S5 and
4P. The sintering had been initiated within 750°C to 800°C for all the three bioactive glass
compositions
 Sintering had been carried out at 800°C, 850°C and 900°C to observe different glass ceramic phase
formation. Na4Ca4Si6O18 (75-1686) and Na2Ca3Si6O16 (77-0386) are the major crystallization phases
observed on post sintering. Na2Ca4(PO4)2SiO4  (33-1229) phase had also been appeared as a minor
phase of the glass ceramic system due to phase separation and simultaneous crystallization.
No major phase transformation had been occurred when the sintering temperature rises from 800°C
to 850°C and 900°C.
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 On post sintering, without pore formers, approximately 31-33 vol.% of Apparent porosity had been
recorded for Single layer - 45S5 bioactive glass ceramic scaffolds. Whereas in the case of 2P and 4P,
approximately 0-0.5 vol.% and 39-42 vol.% of apparent porosity had been attained respectively. Due
to the delayed polymerization in 45S5 and 4P bioactive glass scaffold, the efficient densification had
not been attained.
 The diametral tensile strength of Single layer – 45S5 bioactive glass ceramic scaffolds, without pore
former, had been observed approximately 6-9 MPa on different sintering temperatures. With 30wt.%
pore former, on post sintering, they attained 3-4 MPa of diametral tensile strength. Similarly, with
50wt.% of pore former, it attained 1-1.4 MPa. Approximately (10-14) MPa, (9-10) MPa & (6-7.5)
MPa of diametral tensile strength had been recorded for 2P bioactive glass ceramic scaffolds with
0 wt.%, 30wt.% & 50wt.% of pore former inclusion respectively. Approximately (5-6) MPa, (4-5.5)
MPa and (0.9-1.3) MPa of diametral tensile strength had been recorded for the 4P bioactive glass
ceramic scaffolds with 0 wt.%, 30wt.% & 50wt.% of pore former respectively. On a whole, 2P based
porous single layer scaffolds registered a better diametral tensile strength than the 45S5 and 4P
based scaffolds.
 The similar trend of diametral tensile strength had been followed with flexural strength of 45S5, 2P
and 4P based single layer porous scaffolds. On different sintering temperatures, (7.5-12) MPa,
(3.5-5.1) MPa and (1.1-1.9) MPa of flexural strength had been observed with 45S5 porous single
layer scaffolds with 0wt.%, 30wt.% and 50wt.% pore former addition respectively. Similarly, (24.5-
37.5) MPa, (20-32) MPa and (14.4-23.3) MPa of flexural strength had been recorded for 2P
bioactive glass ceramic scaffolds with 0wt.%, 30wt.% and 50wt.% pore former addition
respectively. Approximately, (4.35-10.15) MPa, (3.8-9.4) MPa & (0.8-2.2) MPa of flexural strength
had been observed with 4P based single layer porous scaffolds with 0wt.%, 30wt.% and 50wt.%
pore former addition respectively. The better flexural strength had been observed with 2P based
porous single layer scaffolds.
 These bioactive glass and glass ceramics are highly hemocompatible, as all the samples recorded
hemolysis of less than 5%. The cell viability of MG-63 cells on these bioactive glass and glass
ceramics are better than the cell viability of the control. The protein adsorption profiles of the
bioactive glass and glass ceramics recorded within the range of 45-60mg of BSA per mg of sample.
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On a whole, the biological invitro characterization shows better compatibility results, which ensures 
that better biological recognition can be attained when the scaffolds had been made out of these 
materials.  
 As the characterization of single layer scaffolds had been carried out, the fabrication of FGS had
been done by uniaxial pressed and sintering method. The apparent porosity and bulk density of the
entire FGS had been evaluated. This evaluation provides effective apparent porosity and effective
bulk density of both dense and porous regions. Approximately (38-42) vol.% and (44-48) vol.% of
effective apparent porosities had been observed on 45S5 (030) and 45S5(050) FGSs respectively.
(15-18) vol.% and (26-27)vol.% of effective apparent porosities had been recorded on 2P(030) and
2P(050) FGSs respectively. Approximately (45-47.5) vol.% and (53-54.5) vol.% of apparent
porosities had been observed with 4P(030) and 4P(050) FGSs respectively. 2P(030) is FGS with low
porosity and 4P(050) FGS attains high amount of porosity.
 The outer dense and inner porous regions had been cut and carved out. The apparent porosity and
bulk density of those scaffold parts had been evaluated. Approximately, (29.6-32.2) vol.% and
(52.2-52.35) vol.% of apparent porosity had been recorded in outer and inner regions of 45S5 (030)
FGS respectively. For 45S5 (050) FGS, (28.5-34.7) vol.% and (58-63) vol.% of apparent porosity
had been recorded in outer and inner region of the scaffold respectively. Approximately (3.1-5.7)
vol.% and (34.1-54.1) vol.% of apparent porosity had been attained on outer and inner region of 2P
(030) FGS respectively. For 2P (050) FGS, (1.9-3.5) vol.% of apparent porosity on outer layer and
(32.9-49.8) vol.% of apparent porosity on inner layer had been observed. In the case of 4P (030)
FGS, (36.6-37.9) vol.% and (50.7-53.2) vol.% of apparent porosities had been recorded on outer
layer and inner layer respectively. Almost (38-42) vol.% and (52-64) vol.% of apparent porosities
had been recorded on the outer and inner layer of the 4P(050) FGS respectively.
 The composition of Single layer 45S5 (0 wt.%) scaffold occupies the outer layers of  45S5(030) and
45S5(050) FGS. Thus, the apparent porosity of single layer scaffolds can be compared with the
graded layers with a similar composition. And again 2P (0wt.%) can be compared with the outer
layers of 2P (030) and 2P (050) FGS scaffolds. Similarly, single layer scaffolds are compared with
the graded layers of similar composition. Even though the sintering mechanism of single layer
scaffolds and FGS are different, as FGS has differential shrinkage issues, there is no drastic
difference between these apparent porosities.
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 To determine splitting tensile strength of the FGSs, Brazilian disc analysis had been carried out.
Beyond the peak load, the applied force drops and again tends to increase. This feature had been
seen due to the porosity gradient architecture. The crack propagates and the deflection travels from
dense region to the porous region and again enters a dense region. 6.15MPa, 1.31 MPa, 6.59 MPa,
3.69 MPa, 2.13 MPa and 0.81 MPa are the calculated splitting tensile strength for 45S5(030),
45S5(050), 2P(030), 2P(050), 4P(030) and 4P(050) respectively. Among these 2P based FGSs have
better splitting tensile strength than the other FGSs.
 Invitro analysis of FGSs, by immersing in SBF, had been carried out. Better stage by stage
morphological development of carbonated hydroxyapatite had been observed with 45S5 based FGS,
within a period of 14 days. 2P and 4P based FGS scaffolds shows minimal deposition of carbonated
hydroxyapatite. Here it can be concluded that 45S5 shows better deposition of carbonated
hydroxyapatite particles than the 2P and 4P based scaffolds.
 By using MG-63 cell line, the invitro analysis on FGSs had been carried out. After addition of MTT
on MG-63 seeded FGS, the surface of the scaffolds will change into blue color due to the formation
of farmazon compounds. The optical density of the Farmazon compound will be directly
proportional to the viable cells present in the well. The intensity of the blue color is high in the
porous region than the dense region. This shows that the cell viability is high in the porous region
than the dense region of the FGSs.  And hence the biomimetic approach is well established with
these FGSs.
 MG-63 cells had been seeded on FGS and microstructures had been taken. The cell adherence, cell
penetration via the pores had been evidently visible with the microstructures. This shows that the
porosity evolved in the FGS had established a better feasibility for biological mechanisms.
 On comparing the 45S5, 2P and 4P based FGSs, 2P based FGSs performs better in mechanical
characterization and 45S5 based FGSs performs better in overall biological characterization.
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4.21 FUTURE WORKS 
 Increasing the overall strength of the FGS
 To study the relationship between the degree of interconnectivity and bioactivity on FGS.
 Incorporation of dissimilar materials for outer and inner layers of FGS
 Introduction of more than two layers to the FGS
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